Psychosoziales und Diabetes (Teil 2)^[*]

Abbildungsverzeichnis

[Abb. 1]: Algorithmus zur ärztlichen Anamnese/Angstdiagnostik bei Diabetes mellitus.
[Abb. 2]: Gestufte Angstbehandlung bei Diabetes mellitus.

^* Deutsche Diabetes-Gesellschaft (DDG), in Kooperation mit: Deutsche Gesellschaft für Psychosomatische Medizin und Ärztliche Psychotherapie (DGPM) e.V., Deutsches Kollegium für Psychosomatische Medizin (DKPM), Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde e.V. (DGPPN), Diabetes und Psychologie e.V.

• Literatur

• 1 Herpertz S, Petrak F, Albus C et al. Evidenzbasierte Diabetes-Leitlinie DDG. Psychosoziales und Diabetes mellitus. Diabetes und Stoffwechsel 2003; 12 (Suppl. 02) 69-94
• 2 WHO – World Health Organization. Internationale Klassifikation psychischer Störungen: ICD-10 Kapitel V (F). Diagnostische Kriterien für Forschung und Praxis. 4. überarbeitete Aufl. Bern: Huber; 2006
• 3 DIMDI. Deutsches Institut für Medizinische Dokumentation und Information Die Internationale statistische Klassifikation der Krankheiten und verwandter Gesundheitsprobleme. 10. Revision, German Modification (ICD-10-GM) 2012 http://www.dimdi.de/static/de/klassi/icd-10-gm/index.htm zuletzt aufgerufen am 10.4.2013
• 4 Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Programm für Nationale VersorgungsLeitlinien. Methoden-Report. 2010 4. Aufl. http://www.versorgungsleitlinien.de/methodik/reports zuletzt aufgerufen am 10.4.2013
• 5 CDA. Clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008; 32 (Suppl. 01) S1-S201 EK IV
• 6 NCC-CC. Type 2 Diabetes: National Clinical Guideline for Management in Primary and Secondary Care (Update). London: Royal College of Physicians; 2008 EK IV
• 7 Funnell MM, Brown TL, Childs BP et al. National Standards for diabetes self-management education. Diab Care 2011; 34 (Suppl. 01) S89-S96 EK IV
• 8 IDF – International Diabetes Federation. Global guidelines for type 2 diabetes. Brussels: International Diabetes Federation; 2012 . EK IV
• 9 Norris SL, Engelgau MM, Venkat NKM. Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diab Care 2001; 24 (03) 561-587 EK Ia
• 10 DAFNE StudyGroup. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ 2002; 325 (7367) 746 EK Ib
• 11 Amsberg S, Anderbro T, Wredling R et al. A cognitive behavior therapy-based intervention among poorly controlled adult type 1 diabetes patients – a randomized controlled trial. Patient Educ Couns 2009; 77 (01) 72-80 EK Ib
• 12 Mühlhauser I, Bruckner I, Berger M et al. Evaluation of an intensified insulin treatment and teaching programme as routine management of type 1 (insulin-dependent) diabetes. The Bucharest-Duesseldorf Study. Diabetologia 1987; 30 (09) 681-690 EK IIa
• 13 Jörgens V, Grüßer M. Behandlungs- und Schulungsprogramm für intensivierte Insulintherapie. 5. Aufl. Köln: Deutscher Ärzte-Verlag; 2009
• 14 Mühlhauser I, Jörgens V, Berger M et al. Bicentric evaluation of a teaching and treatment programme for type 1 (insulin-dependent) diabetic patients: improvement of metabolic control and other measures of diabetes care for up to 22 months. Diabetologia 1983; 25 (06) 470-476 EK IIb
• 15 Pieber TR, Brunner GA, Schnedl WJ et al. Evaluation of a structured outpatient group education program for intensive insulin therapy. Diab Care 1995; 18 (05) 625-630 EK IIb
• 16 Feulner-Krakow G, Krakow D. LINDA – Diabetes-Selbstmanagementschulung. Das Selbstmanagement-Programm für Menschen mit Typ-1- oder Typ-2-Diabetes. Forchheim:: Diabetespraxis Forchheim; 1997 1. Aufl.
• 17 Krakow D, Feulner-Krakow G, Giese M et al. Evaluation der LINDA Diabetes-Selbstmanagementschulung. Diabetes und Stoffwechsel 2004; 13 (02) 77-89 EK IIb
• 18 Brown SA. Studies of educational interventions and outcomes in diabetic adults: a meta-analysis revisited. Patient Educ Couns 1990; 16 (03) 189-215 EK IIa
• 19 Deakin T, McShane CE, Cade JE et al. Group based training for self-management strategies in people with type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2005; 2: CD003417 EK Ib
• 20 Ellis SE, Speroff T, Dittus RS et al. Diabetes patient education: a meta-analysis and meta-regression. Patient Educ Couns 2004; 52 (01) 97-105 EK Ia
• 21 Chodosh J, Morton SC, Mojica W et al. Meta-analysis: chronic disease self-management programs for older adults. Ann Intern Med 2005; 143 (06) 427-438 EK Ia
• 22 Minet L, Moller S, Vach W et al. Mediating the effect of self-care management intervention in type 2 diabetes: a meta-analysis of 47 randomised controlled trials. Patient Educ Couns 2010; 80 (01) 29-41 EK Ia
• 23 Hörnsten A, Stenlund H, Lundman B et al. Improvements in HbA1c remain after 5 years – a follow up of an educational intervention focusing on patients’ personal understandings of type 2 diabetes. Diabetes Research and Clinical Practice 2008; 81 (01) 50-55 EK Ib
• 24 Cochran J, Conn VS. Meta-analysis of Quality of Life Outcomes Following Diabetes Self-management Training. Diabetes Educ 2008; 34 (05) 815-823 EK IIa
• 25 Steed L, Cooke D, Newman S. A systematic review of psychosocial outcomes following education, self-management and psychological interventions in diabetes mellitus. Patient Educ Couns 2003; 51 (01) 5-15 EK Ib
• 26 Berger M, Grüsser M, Jörgens V et al. Behandlungs- und Schulungsprogramm für Typ-2-Diabetiker, die nicht Insulin spritzen. Köln: Deutscher Ärzteverlag; 2010
• 27 Kronsbein P, Jorgens V, Muhlhauser I et al. Evaluation of a structured treatment and teaching programme on non-insulin-dependent diabetes. Lancet 1988; 2 (8625) 1407-1411 EK IIa
• 28 Grüsser M, Bott U, Ellermann P et al. Evaluation of a structured treatment and teaching program for non-insulin-treated type II diabetic outpatients in Germany after the nationwide introduction of reimbursement policy for physicians. Diab Care 1993; 16 (09) 1268-1275 EK IIb
• 29 Berger M, Grüsser M, Jörgens V et al. Behandlungs- und Schulungsprogramm für Typ-2-Diabetiker, die Insulin spritzen (konventionelle Insulintherapie). Köln: Deutscher Ärzteverlag; 2010
• 30 Grüsser M, Hartmann P, Schlottmann N et al. Structured treatment and teaching programme for type 2 diabetic patients on conventional insulin treatment: evaluation of reimbursement policy. Patient Educ Couns 1996; 29 (01) 123-130 EK IIb
• 31 Müller UA, Müller R, Starrach A et al. Should insulin therapy in type 2 diabetic patients be started on an out- or inpatient basis? Results of a prospective controlled trial using the same treatment and teaching programme in ambulatory care and a university hospital. Diabetes Metab 1998; 24 (03) 251-255 EK IIb
• 32 Berger M, Grüsser M, Jörgens V. Behandlungs- und Schulungsprogramm für Typ-2-Diabetiker, die Normalinsulin spritzen (praeprandiale Insulintherapie). 2011. Köln: Deutscher Ärzteverlag;
• 33 Kalfhaus J, Berger M. Insulin treatment with preprandial injections of regular insulin in middle-aged type 2 diabetic patients. A two years observational study. Diabetes Metab 2000; 26 (03) 197-201 EK IIb
• 34 Kulzer B, Hermanns N, Maier B et al. MEDIAS 2 – Mehr Diabetes Selbstmanagement für Typ 2. Ein Schulungs- und Behandlungsprogramm für Menschen mit nicht-insulinpflichtigem Typ-2-Diabetes (MEDIAS 2 Basis). 5. Aufl. Mainz: Kirchheim-Verlag; 2011
• 35 Kulzer B, Hermanns N. „Mehr Diabetes Selbstmanagement Typ 2“: Ein neues Schulungs- und Behandlungsprogramm für Menschen mit nicht-insulinpflichtigem Typ-2-Diabetes. Praxis Klinische Verhaltensmedizin und Rehabilitation 2001; 14 (54) 129-136 EK Ib
• 36 Kulzer B, Hermanns N, Reinecker H et al. Effects of self-management training in Type 2 diabetes: a randomized, prospective trial. Diabet Med 2007; 24 (04) 415-423 EK Ib
• 37 Kulzer B, Hermanns N, Maier B et al. MEDIAS 2 – Mehr Diabetes Selbstmanagement für Typ 2. Ein Schulungs- und Behandlungsprogramm für Menschen mit Typ-2-Diabetes und intensivierter Insulintherapie (MEDIAS 2 ICT). 1. Aufl. Mainz: Kirchheim-Verlag; 2012
• 38 Hermanns N, Kulzer B, Maier B et al. The effect of an education programme (MEDIAS 2 ICT) involving intensive insulin treatment for people with type 2 diabetes. Patient Educ Couns 2012; 86 (02) 226-232 EK Ib
• 39 Brinkmeier U, Frank M, Tewes U. Diabetes II im Gespräch – Therapieprogramm für Typ-II-Diabetiker, die nicht Insulin spritzen. Heidelberg: Spektrum Akademischer Verlag; 1998
• 40 Hartwig A, Tewes U, Brinkmeier U. Die Bedeutung der fachlichen Qualifikation für den Erfolg in der Patientenschulung am Beispiel eines Programms zur verhaltensmedizinischen Behandlung von adipösen Typ-II-Diabetikern. Zeitschrift für Medizinische Psychologie 1999; 8 (02) 65-72 EK III
• 41 Brinkmeier U, Frank M, Tewes U et al. Diabetes & Verhalten – Schulungsprogramm für Typ-2-Diabetiker, die Insulin spritzen. 1. Aufl. Mainz: Kirchheim-Verlag; 2009
• 42 Tewes A, Frank M, Tegtbur U et al. Patientenzentrierte verhaltensmedizinische Schulung – Patienten mit insulinpflichtigem Typ-2-Diabetes profitieren unabhängig von ihrem Bildungsstand. MMW Fortschr Med 2006; 148 (15) 49 EK IIb
• 43 Tewes A, Frank M, Tegtbur U et al. Insulinpflichtiger Typ-2-Diabetes: Patientenzentrierte Schulung verbessert die Stoffwechsellage. Dtsch Arztebl 2006; 103 (06) A341-A345 EK IIb
• 44 Zeyfang A, Feucht I. Fit bleiben und älter werden mit Diabetes. Strukturiertes Schulungsprogramm (SGS) für Typ-2-Diabetiker im höheren Lebensalter. Elsevier 2007
• 45 Braun AK, Kubiak T, Kuntsche J et al. SGS: a structured treatment and teaching programme for older patients with diabetes mellitus – a prospective randomised controlled multi-centre trial. Age Ageing 2009; 38 (04) 390-396 EK Ib
• 46 Cox DJ, Gonder-Frederick L, Ritterband L et al. Blood Glucose Awareness Training: What Is It, Where Is It, and Where Is It Going?. Diabetes Spectr 2006; 19 (01) 43-49 EK IIb
• 47 Fehm-Wolfsdorf G, Kerner W, Peters A. Blutglukosewahrnehmungstraining für Typ 1 Diabetiker (BGAT). . (deutsche Version des „Blood Glucose Awarness Training“ von Cox et al.). 1. Aufl. Lübeck: Lübecker Institut für Verhaltensmedizin; 1997
• 48 Schächinger H, Hegar K, Hermanns N et al. Randomized controlled clinical trial of Blood Glucose Awareness Training (BGAT III) in Switzerland and Germany. J Behav Med 2005; 28 (06) 587-594 EK Ib
• 49 Kulzer B, Hermanns N, Kubiak T et al. HyPOS – Unterzuckerungen besser wahrnehmen, vermeiden und bewältigen. Ein strukturiertes Schulungs- und Behandlungsprogramm für insulinpflichtige Diabetiker mit Hypoglykämieproblemen. Mainz: Kirchheim; 2006
• 50 Kulzer B, Hermanns N, Krichbaum M. HyPOS stationär – Unterzuckerungen besser wahrnehmen, vermeiden und bewältigen. Problemspezifisches Gruppenschulungs- und Behandlungsprogramm für insulinbehandelte Diabetiker mit Hypoglykämieproblemen zur Durchführung im stationären Setting. Mainz: Kirchheim; 2008
• 51 Hermanns N, Kulzer B, Kubiak T et al. The effect of an education programme (HyPOS) to treat hypoglycaemia problems in patients with type 1 diabetes. Diabetes Metab Res Rev 2007; 23 (07) 528-538 EK Ib
• 52 Hermanns N, Kulzer B, Krichbaum M et al. Long-Term Effect of an Education Program (HyPOS) on the Incidence of Severe Hypoglycemia in Patients With Type 1 Diabetes. Diab Care 2010; 33 (03) e36 EK Ib
• 53 Dorresteijn JA, Kriegsman DM, Assendelft WJ et al. Patient education for preventing diabetic foot ulceration. Cochrane Database Syst Rev 2010; (05) CD001488 EK Ia
• 54 Malone JM, Snyder M, Anderson G et al. Prevention of amputation by diabetes education. American Journal of Surgery 1989; 158: 520-523 EK Ib
• 55 Lincoln NB, Radford KA, Game FL et al. Education for secondary prevention of foot ulcers in people with diabetes: a randomised controlled trial. Diabetologia 2008; 51 (11) 1954-1961 EK Ib
• 56 Bloomgarden ZT, Karmally W, Metzger MJ et al. Randomized, controlled trial of diabetic patient education: improved knowledge without improved metabolic status. Diab Care 1987; 10 (03) 263-272 EK Ib
• 57 Ronnemaa T, Hamalainen H, Toikka T et al. Evaluation of the impact of podiatrist care in the primary prevention of foot problems in diabetic subjects. Diab Care 1997; 20 (12) 1833-1837 EK Ib
• 58 Anlauf-Wilhelm B, Fisch R, Gralki A et al. Den Füssen zu liebe (BARFUSS) – Strukturiertes Behandlungs- und Schulungsprogramm für Menschen mit Diabetes und einem diabetischen Fußsyndrom. VDBD 1999
• 59 Hirsch A, Taiyeva O, Clever H-U. Evaluation der Schulung „Den Füßen zuliebe“ für Risikopatienten nach 6 Monaten. Diabetes und Stoffwechsel 2004; 13 (02) 67-76 EK IIb
• 60 Boule NG, Kenny GP, Haddad E et al. Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus. Diabetologia 2003; 46 (08) 1071-1081 EK Ia
• 61 DiLoreto C, Fanelli C, Lucidi P et al. Validation of a counseling strategy to promote the adoption and the maintenance of physical activity by type 2 diabetic subjects. Diab Care 2003; 26 (02) 404-408 EK Ia
• 62 Siegrist M, Zimmer P, Klare WR et al. DiSko: wie Diabetiker zum Sport kommen. Arbeitsgemeinschaft Diabetes und Sport der DDG, 2004
• 63 Siegrist M, Zimmer P, Klare WR et al. Einmalige Übungsstunde verändert das Aktivitätsverhalten bei Typ-2-Diabetikern. Diabetes, Stoffwechsel und Herz 2007; 16 (04) 257-261 EK IIb
• 64 Siegrist M, Zimmer P, Klare WR et al. Bewegung macht Schule – Wirksamkeit und Umsetzbarkeit der Bewegungsschulung DiSko bei Typ-2-Diabetikern. Diabetologie und Stoffwechsel 2009; 4 (02) 118-122 EK IIb
• 65 Duke SA, Colagiuri S, Colagiuri R. Individual patient education for people with type 2 diabetes mellitus. Cochrane Database Syst Rev 2009; (01) CD005268 EK Ib
• 66 Boren SA, Fitzner KA, Panhalkar PS et al. Costs and benefits associated with diabetes education: a review of the literature. Diabetes Educ 2009; 35 (01) 72-96 EK Ia
• 67 Gillett M, Dallosso HM, Dixon S et al. Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis. BMJ 2010; 341: c4093 EK Ib
• 68 Dubois B, Feldman HH, Jacova C et al. Revising the definition of Alzheimer’s disease: a new lexicon. Lancet Neurol 2010; 9 (11) 1118-1127
• 69 Petersen RC, Roberts RO, Knopman DS et al. Mild cognitive impairment: ten years later. Arch Neurol 2009; 66 (12) 1447-1455
• 70 Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256 (03) 183-194 EK IV
• 71 Winblad B, Palmer K, Kivipelto M et al. Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004; 256 (03) 240-246 EK IV
• 72 Draelos MT, Jacobson AM, Weinger K et al. Cognitive function in patients with insulin-dependent diabetes mellitus during hyperglycemia and hypoglycemia. Am J Med 1995; 98 (02) 135-144 EK IIa
• 73 Gonder-Frederick LA, Zrebiec JF, Bauchowitz AU et al. Cognitive function is disrupted by both hypo- and hyperglycemia in school-aged children with type 1 diabetes: a field study. Diab Care 2009; 32 (06) 1001-1006 EK IIa
• 74 Musen G, Simonson DC, Bolo NR et al. Regional brain activation during hypoglycemia in type 1 diabetes. J Clin Endocrinol Metab 2008; 93 (04) 1450-1457 EK IIa
• 75 Wright RJ, Frier BM. Vascular disease and diabetes: is hypoglycaemia an aggravating factor?. Diabetes Metab Res Rev 2008; 24 (05) 353-363 EK IIa
• 76 Cryer PE. Diverse causes of hypoglycemia-associated autonomic failure in diabetes. NEJM 2004; 350 (22) 2272-2279 EK IIa
• 77 Warren RE, Deary IJ, Frier BM. The symptoms of hyperglycaemia in people with insulin-treated diabetes: classification using principal components analysis. Diabetes Metab Res Rev 2003; 19 (05) 408-414 EK IIa
• 78 Strachan MW. The brain as a target organ in Type 2 diabetes: exploring the links with cognitive impairment and dementia. Diabet Med 2011; 28 (02) 141-147 EK IIa
• 79 Cox DJ, Kovatchev BP, Gonder-Frederick LA et al. Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes. Diab Care 2005; 28 (01) 71-77 EK IIa
• 80 Cosway R, Strachan MW, Dougall A et al. Cognitive function and information processing in type 2 diabetes. Diabet Med 2001; 18 (10) 803-810 EK IIa
• 81 Sommerfield AJ, Deary IJ, Frier BM. Acute hyperglycemia alters mood state and impairs cognitive performance in people with type 2 diabetes. Diab Care 2004; 27 (10) 2335-2340 EK IIa
• 82 Ritchie K, Carrière I, Ritchie CW et al. Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors. BMJ 2010; 341: c3885 EK III
• 83 Ryan CM, Geckle MO, Orchard TJ. Cognitive efficiency declines over time in adults with Type 1 diabetes: effects of micro- and macrovascular complications. Diabetologia 2003; 46 (07) 940-948 EK III
• 84 Brands AM, Biessels GJ, de Haan EH et al. The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diab Care 2005; 28 (03) 726-735 EK Ia
• 85 Jacobson AM, Musen G, Ryan CM et al. Long-term effect of diabetes and its treatment on cognitive function. NEJM 2007; 356 (18) 1842-1852 EK Ib
• 86 Brands AM, van den Berg E, Manschot SM et al. A detailed profile of cognitive dysfunction and its relation to psychological distress in patients with type 2 diabetes mellitus. J Int Neuropsychol Soc 2007; 13 (02) 288-297 EK III
• 87 Christman AL, Vannorsdall TD, Pearlson GD et al. Cranial volume, mild cognitive deficits, and functional limitations associated with diabetes in a community sample. Arch Clin Neuropsychol 2010; 25 (01) 49-59 EK III
• 88 Reijmer YD, van den Berg E, Ruis C et al. Cognitive dysfunction in patients with type 2 diabetes. Diabetes Metab Res Rev 2010; 26 (07) 507-519 EK III
• 89 Gregg EW, Yaffe K, Cauley JA et al. Is diabetes associated with cognitive impairment and cognitive decline among older women?. Study of Osteoporotic Fractures Research Group. Arch Intern Med 2000; 160 (02) 174-180 EK III
• 90 Amieva H, Jacqmin-Gadda H, Orgogozo JM et al. The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. Brain 2005; 128 (05) 1093-1101 EK III
• 91 van den Berg E, Kloppenborg RP, Kessels RP et al. Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition. Biochim Biophys Acta 2009; 1792 (05) 470-481 EK III
• 92 Elias PK, Elias MF, D’Agostino RB et al. NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study. Diab Care 1997; 20 (09) 1388-1395 EK III
• 93 Lindeman RD, Romero LJ, LaRue A et al. A biethnic community survey of cognition in participants with type 2 diabetes, impaired glucose tolerance, and normal glucose tolerance: the New Mexico Elder Health Survey. Diab Care 2001; 24 (09) 1567-1572 EK III
• 94 EuroCoDe – European Collaboration on Dementia. 2010 Prevalence of dementia in Europe. Demenz-Zahlen Stand 2006 gemäß Alzheimer Europe. European Collaboration on Dementia. (http://www.alzheimer-europe.org/Research/European-Collaboration-on-Dementia/Prevalence-of-dementia/Prevalence-of-dementia-in-Europe; zuletzt aufgerufen am 6.12.2012) EK III
• 95 Weyerer S. Altersdemenz. Gesundheitsberichterstattung des Bundes (Heft 28). Berlin: Robert Koch-Institut; EK III 2005
• 96 Ferri CP, Prince M, Brayne C et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005; 366 (9503) 2112-2117 EK IV
• 97 Biessels GJ, Staekenborg S, Brunner E et al. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006; 5 (01) 64-74 EK III
• 98 Toro P, Schonknecht P, Schroder J. Type II diabetes in mild cognitive impairment and Alzheimer’s disease: results from a prospective population-based study in Germany. J Alzheimers Dis 2009; 16 (04) 687-691 EK III
• 99 Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetes – systematic overview of prospective observational studies. Diabetologia 2005; 48 (12) 2460-2469 EK III
• 100 Sima AA. Encephalopathies: the emerging diabetic complications. Acta Diabetol 2010; 47 (04) 279-293 EK III
• 101 Young SE, Mainous III AG et al. Hyperinsulinemia and cognitive decline in a middle-aged cohort. Diab Care 2006; 29 (12) 2688-2693 EK III
• 102 van den Berg E, Dekker JM, Nijpels G et al. Cognitive functioning in elderly persons with type 2 diabetes and metabolic syndrome: the Hoorn study. Dement Geriatr Cogn Disord 2008; 26 (03) 261-269 EK III
• 103 Ryan CM, Williams TM, Finegold DN et al. Cognitive dysfunction in adults with type 1 (insulin-dependent) diabetes mellitus of long duration: effects of recurrent hypoglycaemia and other chronic complications. Diabetologia 1993; 36 (04) 329-334 EK III
• 104 Lesage SR, Mosley TH, Wong TY et al. Retinal microvascular abnormalities and cognitive decline: the ARIC 14-year follow-up study. Neurology 2009; 73 (11) 862-868 EK III
• 105 Ding J, Strachan MW, Reynolds RM et al. Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes 2010; 59 (11) 2883-2889 EK III
• 106 Ferguson SC, Blane A, Perros P et al. Cognitive ability and brain structure in type 1 diabetes. Relation to Microangiopathy and preceding severe hypoglycemia. Diabetes 2003; 52: 149-156 EK III
• 107 Saczynski JS, Jonsdottir MK, Garcia ME et al. Cognitive impairment: an increasingly important complication of type 2 diabetes: the age, gene/environment susceptibility – Reykjavik study. Am J Epidemiol 2008; 168 (10) 1132-1139 EK III
• 108 Dore GA, Elias MF, Robbins MA et al. Presence of the APOE epsilon4 allele modifies the relationship between type 2 diabetes and cognitive performance: the Maine-Syracuse Study. Diabetologia 2009; 52 (12) 2551-2560 EK III
• 109 Sinclair AJ, Girling AJ, Bayer AJ. Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self-management and use of care services. All Wales Research into Elderly (AWARE) Study. Diabetes Res Clin Pract 2000; 50 (03) 203-212 EK III
• 110 Baliga BS, Weinberger J. Diabetes and stroke: part one – risk factors and pathophysiology. Curr Cardiol Rep 2006; 8 (01) 23-28 EK III
• 111 Furie K, Inzucchi SE. Diabetes mellitus, insulin resistance, hyperglycemia, and stroke. Curr Neurol Neurosci Rep 2008; 8 (01) 12-19 EK III
• 112 Sander D, Sander K, Poppert H. Review: Stroke in type 2 diabetes. Br J Diabetes Vasc Dis 2008; 8 (05) 222-229 EK III
• 113 Schoenle EJ, Schoenle D, Molinari L et al. Impaired intellectual development in children with Type I diabetes: association with HbA (1c), age at diagnosis and sex. Diabetologia 2002; 45 (01) 108-114 EK III
• 114 Bruce DG, Davis WA, Casey GP et al. Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study. Diabetologia 2009; 52 (09) 1808-1815 EK III
• 115 Whitmer RA, Karter AJ, Yaffe K et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009; 301 (15) 1565-1572 EK III
• 116 ADA. Standards of Medical Care in Diabetes – 2011. Diab Care 2011; 34 (Suppl. 01) S11-S61 EK IV
• 117 Ko SB, Bae HJ, Lee SH et al. Teaching NeuroImage: hippocampal involvement in a patient with hypoglycemic coma. Neurology 2008; 71 (20) e63 EK IV
• 118 Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (DGPPN), Deutsche Gesellschaft für Neurologie (DGN), in Zusammenarbeit mit der Deutschen Alzheimer Gesellschaft e.V. (DAlzG). Selbsthilfe Demenz. S3-Leitlinie Demenzen. 2009 http://www.awmf.org/uploads/tx_szleitlinien/038-013_S3_Demenzen_lang_11-2009_11-2011.pdf zuletzt aufgerufen am 10.4.2013) EK IV
• 119 DEGAM – Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin. Demenz. DEGAM-Leitlinie Nr. 12. 2008 http://leitlinien.degam.de/uploads/media/LL-12_Langfassung_TJ_03_korr_01.pdf zuletzt aufgerufen am 10.4.2013 EK IV
• 120 Strawbridge WJ, Shema SJ, Balfour JL et al. Antecedents of frailty over three decades in an older cohort. J Gerontol B Psychol Sci Soc Sci 1998; 53 (01) S9-S16 EK III
• 121 Kessler J, Calabrese P, Kalbe E et al. DemTect. Ein neues Screening-Verfahren zur Unterstützung der Demenzdiagnostik. Psycho 2000; 26 (06) 343-347
• 122 Kessler J, Markowitsch HJ, Denzler P. Mini-Mental-Status-Test (MMST). Göttingen: Beltz; 2000
• 123 Shulman KI, Pushkar GoldD, Cohen CA et al. Clock-drawing and dementia in the community: A longitudinal study. Int J Geriat Psychiatry 1993; 8 (06) 487-496
• 124 Ihl R, Grass-Kapanke B. Test zur Früherkennung von Demenzen mit Depressionsabgrenzung (TFDD). Eigenverlag; 2000
• 125 Reisberg B, Finkel S, Overall J et al. The Alzheimer’s disease activities of daily living international scale (ADL-IS). Int Psychogeriatr 2001; 13 (02) 163-181
• 126 Mahoney F, Barthel D. Functional evaluation: The Barthel Index. Md State Med J 1965; 14: 61-65
• 127 Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9 (03) 179-186
• 128 De Galan BE, Zoungas S, Chalmers J et al. Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia 2009; 52 (11) 2328-2336 EK Ib
• 129 Cukierman-Yaffe T, Gerstein HC, Williamson JD et al. Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial. Diab Care 2009; 32 (02) 221-226 EK Ib
• 130 Launer LJ, Miller ME, Williamson JD et al. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol 2011; 10 (11) 969-977 EK Ib
• 131 Ryan CM, Freed MI, Rood JA et al. Improving metabolic control leads to better working memory in adults with type 2 diabetes. Diab Care 2006; 29 (02) 345-351 EK Ib
• 132 Hader C, Beischer W, Braun A et al. Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Alter. Diabetes und Stoffwechsel 2004; 13 (Suppl. 02) S31-S56 EK IV
• 133 Zeyfang A, Bahrmann A, Wernecke J. Diabetes mellitus im Alter. Diabetologie und Stoffwechsel 2012; 7 (Suppl. 02) S163-S169 EK IV
• 134 Arbeitskreis FoDiAl. Fortbildung Diabetes in der Altenpflege – FoDiAl. Curriculum für Altenpflegekräfte. Arbeitskreis FoDiAl (Hrsg.) 2006 http://www.fodial.de zuletzt aufgerufen am 16.4.2014. EK IV
• 135 Sinclair AJ, Woodhouse K. Meeting the challenge of diabetes in the aged. J R Soc Med 1994; 87 (10) 607 EK IV
• 136 Seitz HK, Bühringer G, Mann K. Grenzwerte für den Konsum alkoholischer Getränke. In: Deutsche Hauptstelle für Suchtfragen (Hrsg.) Jahrbuch Sucht. Geesthacht: Neuland Verlagsgeselschaft; 2008: p. 205-210 EK IV
• 137 World Health Organization. Global Status Report on Alcohol and Health. Geneva, Switzerland: WHO Press; 2011 EK IV
• 138 Spangler JG, Konen JC, McGann KP. Prevalence and predictors of problem drinking among primary care diabetic patients. J Fam Pract 1993; 37 (04) 370-375 EK III
• 139 Kruse J, Schmitz N, Thefeld W. On the association between diabetes and mental disorders in a community sample: results from the German National Health Interview and Examination Survey. Diab Care 2003; 26 (06) 1841-1846 EK III
• 140 Jacobson AM, Hauser ST, Willett JB et al. Psychological adjustment to IDDM: 10-year follow-up of an onset cohort of child and adolescent patients. Diab Care 1997; 20 (05) 811-818 EK IIb
• 141 Pabst A, Piontek D, Kraus L et al. Substanzkonsum und substanzbezogene Störungen. Sucht 2010; 56 (05) 327-336 EK III
• 142 Jacobi F, Wittchen HU, Holting C et al. Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychol Med 2004; 34 (04) 597-611 EK IIb
• 143 Carlsson S, Hammar N, Grill V. Alcohol consumption and type 2 diabetes – Meta-analysis of epidemiological studies indicates a U-shaped relationship. Diabetologia 2005; 48 (06) 1051-1054 EK IIb
• 144 Koppes LL, Dekker JM, Hendriks HF et al. Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies. Diab Care 2005; 28 (03) 719-725 EK IIb
• 145 Baliunas DO, Taylor BJ, Irving H et al. Alcohol as a risk factor for type 2 diabetes: A systematic review and meta-analysis. Diab Care 2009; 32 (11) 2123-2132 EK IIb
• 146 Djousse L, Biggs ML, Mukamal KJ et al. Alcohol consumption and type 2 diabetes among older adults: the Cardiovascular Health Study. Obesity 2007; 15 (07) 1758-1765 EK IIb
• 147 Djousse L, Arnett DK, Eckfeldt JH et al. Alcohol consumption and metabolic syndrome: does the type of beverage matter?. Obes Res 2004; 12 (09) 1375-1385 EK IIb
• 148 Freiberg MS, Cabral HJ, Heeren TC et al. Alcohol consumption and the prevalence of the Metabolic Syndrome in the U.S.: a cross-sectional analysis of data from the Third National Health and Nutrition Examination Survey. Diab Care 2004; 27 (12) 2954-2959 EK IIb
• 149 Yoon YS, Oh SW, Baik HW et al. Alcohol consumption and the metabolic syndrome in Korean adults: the 1998 Korean National Health and Nutrition Examination Survey. Am J Clin Nutr 2004; 80 (01) 217-224 EK IIb
• 150 AlKerwi A, Boutsen M, Vaillant M et al. Alcohol consumption and the prevalence of metabolic syndrome: a meta-analysis of observational studies. Atherosclerosis 2009; 204 (02) 624-635 EK IIb
• 151 Hamaguchi M, Kojima T, Ohbora A et al. Protective effect of alcohol consumption for fatty liver but not metabolic syndrome. World J Gastroenterol 2012; 18 (02) 156-167 EK III
• 152 Baik I, Shin C. Prospective study of alcohol consumption and metabolic syndrome. Am J Clin Nutr 2008; 87 (05) 1455-1463 EK IIb
• 153 Buja A, Scafato E, Sergi G et al. Alcohol consumption and metabolic syndrome in the elderly: results from the Italian longitudinal study on aging. Eur J Clin Nutr 2010; 64 (03) 297-307 EK IIb
• 154 Hodge AM, English DR, O’Dea K et al. Alcohol intake, consumption pattern and beverage type, and the risk of Type 2 diabetes. Diabet Med 2006; 23 (06) 690-697 EK IIb
• 155 Jordan HT, Tabaei BP, Nash D et al. Metabolic syndrome among adults in New York City. 2004 New York City Health and Nutrition Examination Servey. Prev Chronic Dis 2012; 9: 100260 EK IIb
• 156 Davies MJ, Baer DJ, Judd JT et al. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial. JAMA 2002; 287 (19) 2559-2562 EK Ib
• 157 Joosten MM, Beulens JW, Kersten S et al. Moderate alcohol consumption increases insulin sensitivity and ADIPOQ expression in postmenopausal women: a randomised, crossover trial. Diabetologia 2008; 51 (08) 1375-1381 EK Ib
• 158 Bell RA, Mayer-Davis EJ, Martin MA et al. Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study. Diab Care 2000; 23 (11) 1630-1636 EK III
• 159 Magis DC, Jandrain BJ, Scheen AJ. Alcohol, insulin sensitivity and diabetes. Rev Med Liege 2003; 58 (07) 501-507 EK III
• 160 Kiechl S, Willeit J, Poewe W et al. Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study). BMJ 1996; 313 (7064) 1040-1044 EK IIb
• 161 Yokoyama H. Beneficial effects of ethanol consumption on insulin resistance are only applicable to subjects without obesity or insulin resistance; drinking is not necessarily a remedy for metabolic syndrome. Int J Environ Res Public Health 2011; 8 (07) 3019-3031 EK III
• 162 Wakabayashi I. Associations between alcohol drinking and multiple risk factors for atherosclerosis in smokers and nonsmokers. Angiology 2010; 61 (05) 495-503 EK III
• 163 Wakabayashi I. Impact of body weight on the relationship between alcohol intake and blood pressure. Alcohol Alcohol 2009; 44 (02) 204-210 EK III
• 164 Balakrishnan V, Unnikrishnan AG, Thomas V et al. Chronic pancreatitis. A prospective nationwide study of 1,086 subjects from India. JOP 2008; 9 (05) 593-600 EK III
• 165 Choudhuri G, Lakshmi CP, Goel A. Pancreatic diabetes. Trop Gastroenterol 2009; 30 (02) 71-75 EK III
• 166 Brand-Miller JC, Fatema K, Middlemiss C et al. Effect of alcoholic beverages on postprandial glycemia and insulinemia in lean, young, healthy adults. Am J Clin Nutr 2007; 85 (06) 1545-1551 EK IIa
• 167 Ahmed AT, Karter AJ, Warton EM et al. The relationship between alcohol consumption and glycemic control among patients with diabetes: the Kaiser Permanente Northern California Diabetes Registry. J Gen Intern Med 2008; 23 (03) 275-282 EK IIb
• 168 Bantle AE, Thomas W, Bantle JP. Metabolic effects of alcohol in the form of wine in persons with type 2 diabetes mellitus. Metabolism 2008; 57 (02) 241-245 EK Ib
• 169 Avogaro A, Beltramello P, Gnudi L et al. Alcohol intake impairs glucose counterregulation during acute insulin-induced hypoglycemia in IDDM patients. Evidence for a critical role of free fatty acids. Diabetes 1993; 42 (11) 1626-1634 EK IIa
• 170 Turner BC, Jenkins E, Kerr D et al. The effect of evening alcohol consumption on next-morning glucose control in type 1 diabetes. Diab Care 2001; 24 (11) 1888-1893 EK IIa
• 171 Richardson T, Weiss M, Thomas P et al. Day after the night before: influence of evening alcohol on risk of hypoglycemia in patients with type 1 diabetes. Diab Care 2005; 28 (07) 1801-1802 EK Ib
• 172 Pedersen-Bjergaard U, Reubsaet JL, Nielsen SL et al. Psychoactive drugs, alcohol, and severe hypoglycemia in insulin-treated diabetes: analysis of 141 cases. Am J Med 2005; 118 (03) 307-310 EK III
• 173 Strachan MWJ. Frequency, causes and risk factors for hypoglycaemia in type 1 diabetes. In: Frier BM, Fisher M, (eds.) Hypoglycaemia in Clinical Diabetes. 2 ed. Chichester: John Wiley & Sons; 2007: 49-81 EK III
• 174 Richardson T, Kerr D. Moderators, monitoring and management of hypoglycaemia. In: Frier BM, Fisher M, (eds.). Hypoglycaemia in Clinical Diabetes. 2 ed. Chichester: John Wiley & Sons; 2007: 101-120 EK IIb
• 175 Fravel MA, McDanel DL, Ross MB et al. Special considerations for treatment of type 2 diabetes mellitus in the elderly. Am J Health Syst Pharm 2011; 68 (06) 500-509 EK III
• 176 Gadsby R, Galloway M, Barker P et al. Prescribed medicines for elderly frail people with diabetes resident in nursing homes-issues of polypharmacy and medication costs. Diabet Med 2012; 29 (01) 136-139 EK III
• 177 Ahmed AT, Karter AJ, Liu J. Alcohol consumption is inversely associated with adherence to diabetes self-care behaviours. Diabet Med 2006; 23 (07) 795-802 EK IIb
• 178 Karter AJ, Ferrara A, Darbinian JA et al. Self-monitoring of blood glucose: language and financial barriers in a managed care population with diabetes. Diab Care 2000; 23 (04) 477-483 EK IIb
• 179 Chew LD, Nelson KM, Young BA et al. Association between alcohol consumption and diabetes preventive practices. Fam Med 2005; 37 (08) 589-594 EK IIb
• 180 Altenburg N, Joraschky P, Barthel A et al. Alcohol consumption and other psycho-social conditions as important factors in the development of diabetic foot ulcers. Diabet Med 2011; 28 (02) 168-174 EK III
• 181 World Health Organization. Global Status Report on Noncommunicable Diseases 2010. Geneva, Switzerland: WHO Press; 2011 EK III
• 182 Danaei G, Ding EL, Mozaffarian D et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med 2009; 6 (04) e1000058 EK IIb
• 183 Borch-Johnsen K, Helweg-Larsen K. Sudden death and human insulin: is there a link?. Diabet Med 1993; 10 (03) 255-259 EK III
• 184 Ronksley PE, Brien SE, Turner BJ et al. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ 2011; 342: d671 EK IIb
• 185 Djousse L, Lee IM, Buring JE et al. Alcohol consumption and risk of cardiovascular disease and death in women: potential mediating mechanisms. Circulation 2009; 120 (03) 237-244 EK IIb
• 186 Hillbom M, Saloheimo P, Juvela S. Alcohol consumption, blood pressure, and the risk of stroke. Curr Hypertens Rep 2011; 13 (03) 208-213 EK III
• 187 Targher G. Elevated serum gamma-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer – a narrative review. Clin Chem Lab Med 2010; 48 (02) 147-157 EK IIb
• 188 Sluik D, Beulens JW, Weikert C et al. Gamma-glutamyltransferase, cardiovascular disease and mortality in individuals with diabetes mellitus. Diabetes Metab Res Rev 2012; 28 (03) 284-288 EK IIb
• 189 Beulens JW, Kruidhof JS, Grobbee DE et al. Alcohol consumption and risk of microvascular complications in type 1 diabetes patients: the EURODIAB Prospective Complications Study. Diabetologia 2008; 51 (09) 1631-1638 EK IIb
• 190 Feuerlein W, Küfner H, Ringer C, Antons-Volmerg K. MALT: Münchener Alkoholismus Test. Göttingen: Hogrefe; 1999
• 191 Funke W, Funke J, Klein M, Scheller R. Trierer Alkoholismusinventar (TAI). Göttingen: Hogrefe; 1987
• 192 Rumpf HJ, Hapke U, John U. Deutsche Version des CAGE Fragebogens (CAGE-G). In: Glöckner-Rist A, Rist F, Küfner H, (Hrsg.). Elektronisches Handbuch zu Erhebungsinstrumenten im Suchtbereich (EHES). Version 3.00 Mannheim: Zentrum für Umfragen, Methoden und Analysen; 2003
• 193 Rumpf HJ, Hapke U, John U. Der Lübecker Alkoholabhängigkeits- und -missbrauchs-Screening-Test (LAST). In: Glöckner-Rist A, Rist F, Küfner H, (Hrsg.). Elektronisches Handbuch zu Erhebungsinstrumenten im Suchtbereich (EHES). Version 3.00 Mannheim: Zentrum für Umfragen, Methoden und Analysen; 2003
• 194 Rumpf HJ, Meyer C, Hapke U et al. Deutsche Version des Alcohol Use Disorders Identification Test (AUDIT-G-L). In: Glöckner-Rist A, Rist F, Küfner H, (Hrsg.). Elektronisches Handbuch zu Erhebungsinstrumenten im Suchtbereich (EHES). Version 3.00 Mannheim: Zentrum für Umfragen, Methoden und Analysen; 2003
• 195 Rist F, Scheuren B, Demmel R et al. Der Münsteraner Alcohol Use Disorders Identification Test (AUDIT-G-M). In: Glöckner-Rist A, Rist F, Küfner H, (Hrsg.). Elektronisches Handbuch zu Erhebungsinstrumenten im Suchtbereich (EHES). Version 3.00 Mannheim: Zentrum für Umfragen, Methoden und Analysen; 2003
• 196 Bischof G, Reinhardt S, Grothues J et al. Development and evaluation of a screening instrument for alcohol-use disorders and at-risk drinking: the brief alcohol screening instrument for medical care (BASIC). J Stud Alcohol Drugs 2007; 68 (04) 607-614
• 197 Schneider S, Margraf J. Diagnostisches Interview bei psyschischen Störungen (DIPS). 4. überarbeitete Aufl. Berlin: Springer; 2011
• 198 Wittchen H-U, Pfister H. DIA-X-Interview. Frankfurt: Swets & Zeitlinger; 1997
• 199 Wittchen H-U, Lachner G, Perkonigg A et al. Muenchner Composite International Diagnostic Interview (M-CIDI). Frankfurt: Swets & Zeitlinger; 1996
• 200 Wittchen H-U, Zaudig M, Fydrich T. SKID. Strukturiertes Klinisches Interview für DSM-IV. Achse I und II. Handanweisung. Göttingen: Hogrefe; 1997
• 201 Schippers GM, Broekman TG, Buchholz A. MATE-de 2.1. Handbuch und Leitfaden. . Deutsche Bearbeitung: A. Buchholz, H. Küfner, L. Kraus, & F. Rist 2011
• 202 Rist F, Demmel R, Hapke U et al. Riskanter schädlicher und abhängiger Alkoholkonsum: Screening, Diagnostik, Kurzintervention. Leitlinien der AWMF. Sucht 2004; 50 (02) 102-112 EK IV
• 203 Jepson RG, Harris FM, Platt S et al. The effectiveness of interventions to change six health behaviours: a review of reviews. BMC Public Health 2010; 10: 538 EK IV
• 204 Whitlock EP, Green CA, Polen MR et al. Behavioral Counseling Interventions in Primary Care to Reduce Risky/Harmful Alcohol Use. 2004; http://www.ncbi.nlm.nih.gov/books/NBK42863/ [On-line]. PM:20722127. zuletzt aufgerufen am 10.5.2013. EK Ib
• 205 Bertholet N, Daeppen JB, Wietlisbach V et al. Reduction of alcohol consumption by brief alcohol intervention in primary care: systematic review and meta-analysis. Arch Intern Med 2005; 165 (09) 986-995 EK Ia
• 206 Cuijpers P, Riper H, Lemmers L. The effects on mortality of brief interventions for problem drinking: a meta-analysis. Addiction 2004; 99 (07) 839-845 EK Ia
• 207 Kaner EF, Beyer F, Dickinson HO et al. Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev 2007; 2: CD004148 EK Ia
• 208 Fleming M, Brown R, Brown D. The efficacy of a brief alcohol intervention combined with %CDT feedback in patients being treated for type 2 diabetes and/or hypertension. J Stud Alcohol 2004; 65 (05) 631-637 EK Ib
• 209 Engler PA, Ramsey SE, Stein MD. Brief alcohol intervention among diabetic patients: a pilot study. Presented at: Annual Meeting of the Society for Behavioral Medicine; March 26–29, 2008; San Diego, CA. 2008. EK IIa
• 210 Ramsey SE, Engler PA, Harrington M et al. Brief Alcohol Intervention Among At-Risk Drinkers with Diabetes. Subst Abuse 2010; 4: 1-8 EK IIa
• 211 Saitz R. Alcohol screening and brief intervention in primary care: Absence of evidence for efficacy in people with dependence or very heavy drinking. Drug Alcohol Rev 2010; 29 (06) 631-640 EK Ia
• 212 Anderson P, Chisholm D, Fuhr DC. Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol. Lancet 2009; 373 (9682) 2234-2246 EK IV
• 213 Room R, Babor T, Rehm J. Alcohol and public health. Lancet 2005; 365 (9458) 519-530 EK IV
• 214 Mundle G, Banger M, Mugele B et al. AWMF-Behandlungsleitlinie: Akutbehandlung alkoholbezogener Störungen. Sucht 2003; 49 (03) 147-167 EK IV
• 215 Schmidt LG, Gastpar M, Falkai P et al. Evidenzbasierte Suchtmedizin. Behandlungsleitlinie Substanzbezogene Störungen. Köln: Deutscher Ärzte-Verlag; 2006. EK IV
• 216 Pabst A, Piontek D, Kraus L et al. Substanzkonsum und substanzbezogene Störungen. Sucht 2010; 56 (05) 327-336 EK IIb
• 217 Hayes DK, Fan AZ, Smith RA et al. Trends in selected chronic conditions and behavioral risk factors among women of reproductive age, behavioral risk factor surveillance system, 2001–2009. Prev Chronic Dis 2011; 8 (06) A120 EK IIb
• 218 Kraus L, Pabst A, Piontek D et al. Trends des Substanzkonsums und substanzbezogener Störungen. Sucht 2010; 56 (05) 337-347 EK IIb
• 219 Altenhofen L, Brenner G, Hagen B et al. Qualitätssicherungsbericht 2005. Disease-Management-Programme in Nordrhein. Düsseldorf: EK IIb 2006
• 220 Hagen B, Altenhofen L, Blaschy S et al. Qualitätssicherungsbericht 2009. Disease-Management-Programme in Nordrhein. Düsseldorf: EK IIb 2010
• 221 Nakanishi N, Nakamura K, Matsuo Y et al. Cigarette smoking and risk for impaired fasting glucose and type 2 diabetes in middle-aged Japanese men. Ann Intern Med 2000; 133 (03) 183-191 EK IIb
• 222 Houston TK, Person SD, Pletcher MJ et al. Active and passive smoking and development of glucose intolerance among young adults in a prospective cohort: CARDIA study. BMJ 2006; 332 (7549) 1064-1069 EK IIb
• 223 Rafalson L, Donahue RP, Dmochowski J et al. Cigarette smoking is associated with conversion from normoglycemia to impaired fasting glucose: the Western New York Health Study. Ann Epidemiol 2009; 19 (06) 365-371 EK IIb
• 224 Willi C, Bodenmann P, Ghali WA et al. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2007; 298 (22) 2654-2664 EK Ia
• 225 Sairenchi T, Iso H, Nishimura A et al. Cigarette smoking and risk of type 2 diabetes mellitus among middle-aged and elderly Japanese men and women. Am J Epidemiol 2004; 160 (02) 158-162 EK IIb
• 226 Lyssenko V, Jonsson A, Almgren P et al. Clinical risk factors, DNA variants, and the development of type 2 diabetes. NEJM 2008; 359 (21) 2220-2232 EK IIb
• 227 Jee SH, Foong AW, Hur NW et al. Smoking and risk for diabetes incidence and mortality in Korean men and women. Diab Care 2010; 33 (12) 2567-2572 EK IIb
• 228 Ley SH, Hegele RA, Harris SB et al. HNF1A G319S variant, active cigarette smoking and incident type 2 diabetes in Aboriginal Canadians: a population-based epidemiological study. BMC Med Genet 2011; 12: 1 EK IIb
• 229 Liu T, Chen WQ, David SP et al. Interaction between heavy smoking and CYP2A6 genotypes on type 2 diabetes and its possible pathways. Eur J Endocrinol 2011; 165 (06) 961-967 EK IIb
• 230 Morgan TM, Crawford L, Stoller A et al. Acute effects of nicotine on serum glucose insulin growth hormone and cortisol in healthy smokers. Metabolism 2004; 53 (05) 578-582 EK Ib
• 231 Nilsson PM, Gudbjornsdottir S, Eliasson B et al. Smoking is associated with increased HbA1c values and microalbuminuria in patients with diabetes – data from the National Diabetes Register in Sweden. Diabetes Metab 2004; 30 (03) 261-268 EK IIb
• 232 Sargeant LA, Khaw KT, Bingham S et al. Cigarette smoking and glycaemia: the EPIC-Norfolk Study. European Prospective Investigation into Cancer. Int J Epidemiol 2001; 30 (03) 547-554 EK III
• 233 Morrish NJ, Stevens LK, Fuller JH et al. Risk factors for macrovascular disease in diabetes mellitus: the London follow-up to the WHO Multinational Study of Vascular Disease in Diabetics. Diabetologia 1991; 34 (08) 590-594 EK IIb
• 234 Al-Delaimy WK, Manson JE, Solomon CG et al. Smoking and risk of coronary heart disease among women with type 2 diabetes mellitus. Arch Intern Med 2002; 162 (03) 273-279 EK IIb
• 235 Cederholm J, Eeg-Olofsson K, Eliasson B et al. Risk prediction of cardiovascular disease in type 2 diabetes: a risk equation from the Swedish National Diabetes Register. Diab Care 2008; 31 (10) 2038-2043 EK IIb
• 236 Nilsson PM, Cederholm J, Eeg-Olofsson K et al. Smoking as an independent risk factor for myocardial infarction or stroke in type 2 diabetes: a report from the Swedish National Diabetes Register. Eur J Cardiovasc Prev Rehabil 2009; 16 (04) 506-512 EK IIb
• 237 Kothari V, Stevens RJ, Adler AI et al. UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke 2002; 33 (07) 1776-1781 EK IIb
• 238 Kengne AP, Nakamura K, Barzi F et al. Smoking, diabetes and cardiovascular diseases in men in the Asia Pacific region. J Diabetes 2009; 1 (03) 173-181 EK IIb
• 239 Ford ES, De Stefano F. Risk factors for mortality from all causes and from coronary heart disease among persons with diabetes. Findings from the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Am J Epidemiol 1991; 133 (12) 1220-1230 EK IIb
• 240 Al-Delaimy WK, Willett WC, Manson JE et al. Smoking and mortality among women with type 2 diabetes: The Nurses’ Health Study cohort. Diab Care 2001; 24 (12) 2043-2048 EK IIb
• 241 Fuller JH, Stevens LK, Wang SL. Risk factors for cardiovascular mortality and morbidity: the WHO Mutinational Study of Vascular Disease in Diabetes. Diabetologia 2001; 44 (Suppl. 02) S54-S64 EK IIb
• 242 De Stefano F, Ford ES, Newman J et al. Risk factors for coronary heart disease mortality among persons with diabetes. Ann Epidemiol 1993; 3 (01) 27-34 EK IIb
• 243 Tan AU, Hoffman B, Rosas SE. Patient perception of risk factors associated with chronic kidney disease morbidity and mortality. Ethn Dis 2010; 20 (02) 106-110 EK III
• 244 Retnakaran R, Cull CA, Thorne KI et al. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes 2006; 55 (06) 1832-1839 EK IIb
• 245 Ritz E, Orth SR. Adverse effect of smoking on the renal outcome of patients with primary hypertension. Am J Kidney Dis 2000; 35 (04) 767-769 EK III
• 246 Ritz E, Ogata H, Orth SR. Smoking: a factor promoting onset and progression of diabetic nephropathy. Diabetes Metab 2000; 26 (Suppl. 04) 54-63 EK III
• 247 Chuahirun T, Simoni J, Hudson C et al. Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes. Am J Med Sci 2004; 327 (02) 57-67 EK IIa
• 248 Chuahirun T, Wesson DE. Cigarette smoking predicts faster progression of type 2 established diabetic nephropathy despite ACE inhibition. Am J Kidney Dis 2002; 39 (02) 376-382 EK IIb
• 249 Chuahirun T, Khanna A, Kimball K et al. Cigarette smoking and increased urine albumin excretion are interrelated predictors of nephropathy progression in type 2 diabetes. Am J Kidney Dis 2003; 41 (01) 13-21 EK IIb
• 250 Rossing K, Christensen PK, Hovind P et al. Progression of nephropathy in type 2 diabetic patients. Kidney Int 2004; 66 (04) 1596-1605 EK IIb
• 251 Orth SR, Schroeder T, Ritz E et al. Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus. Nephrol Dial Transplant 2005; 20 (11) 2414-2419 EK IIb
• 252 Phisitkul K, Hegazy K, Chuahirun T et al. Continued smoking exacerbates but cessation ameliorates progression of early type 2 diabetic nephropathy. Am J Med Sci 2008; 335 (04) 284-291 EK III
• 253 Yokoyama H, Sone H, Oishi M et al. Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15). Nephrol Dial Transplant 2009; 24 (04) 1212-1219 EK III
• 254 Chaturvedi N, Stephenson JM, Fuller JH. The relationship between smoking and microvascular complications in the EURODIAB IDDM Complications Study. Diab Care 1995; 18 (06) 785-792 EK IIb
• 255 Roy MS, Affouf M. Six-year progression of retinopathy and associated risk factors in African American patients with type 1 diabetes mellitus: the New Jersey 725. Arch Ophthalmol 2006; 124 (09) 1297-1306 EK Ib
• 256 Stratton IM, Kohner EM, Aldington SJ et al. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 2001; 44 (02) 156-163 EK IIb
• 257 Tesfaye S, Chaturvedi N, Eaton SE et al. Vascular risk factors and diabetic neuropathy. NEJM 2005; 352 (04) 341-350 EK IIb
• 258 Tamer A, Yildiz S, Yildiz N et al. The prevalence of neuropathy and relationship with risk factors in diabetic patients: a single-center experience. Med Princ Pract 2006; 15 (03) 190-194 EK III
• 259 Will JC, Galuska DA, Ford ES et al. Cigarette smoking and diabetes mellitus: evidence of a positive association from a large prospective cohort study. Int J Epidemiol 2001; 30 (03) 540-546 EK IIb
• 260 Hur NW, Kim HC, Nam CM et al. Smoking cessation and risk of type 2 diabetes mellitus: Korea Medical Insurance Corporation Study. Eur J Cardiovasc Prev Rehabil 2007; 14 (02) 244-249 EK IIb
• 261 Voulgari C, Katsilambros N, Tentolouris N. Smoking cessation predicts amelioration of microalbuminuria in newly diagnosed type 2 diabetes mellitus: a 1-year prospective study. Metabolism 2011; 60 (10) 1456-1464 EK IIb
• 262 Eliasson B, Attvall S, Taskinen MR et al. Smoking cessation improves insulin sensitivity in healthy middle-aged men. Eur J Clin Invest 1997; 27 (05) 450-456 EK IIb
• 263 Mikhailidis DP, Papadakis JA, Ganotakis ES. Smoking, diabetes and hyperlipidaemia. J R Soc Health 1998; 118 (02) 91-93 EK IIb
• 264 Iino K, Iwase M, Tsutsu N et al. Smoking cessation and glycaemic control in type 2 diabetic patients. Diabetes Obes Metab 2004; 6 (03) 181-186 EK IIa
• 265 Bodmer CW, MacFarlane IA, Flavell HJ et al. How accurate is the smoking history in newly diagnosed diabetic patients?. Diabetes Res Clin Pract 1990; 10 (03) 215-220 EK III
• 266 Ardron M, MacFarlane IA, Robinson C et al. Anti-smoking advice for young diabetic smokers: is it a waste of breath?. Diabet Med 1988; 5 (07) 667-670 EK III
• 267 Wakefield M, Wilson D, Phillips P et al. Smoking-related beliefs and behaviour of South Australians with diabetes. Aust J Public Health 1995; 19 (03) 309-312 EK III
• 268 Schumann A, Rumpf HJ, Meyer C et al. Deutsche Version des Fagerström-Test for Nicotine Dependence (FTND-G) und des Heaviness of Smoking Index (HSI-G). In: Glöckner-Rist A, Rist F, Küfner H, (Hrsg.). Elektronisches Handbuch zu Erhebungsinstrumenten im Suchtbereich (EHES). Version 3.00 Mannheim: Zentrum für Umfragen, Methoden und Analysen; 2003
• 269 Mottillo S, Filion KB, Belisle P et al. Behavioural interventions for smoking cessation: a meta-analysis of randomized controlled trials. Eur Heart J 2009; 30 (06) 718-730 EK Ia
• 270 Batra A, Schütz CG, Lindinger P. Tabakabhängigkeit. In: Schmidt LG, Gastpar M, Falkai P, Gaebel W, (Hrsg.) Evidenzbasierte Suchtmedizin. Behandlungsleitlinie Substanzbezogener Störungen. Köln: Deutscher Ärzte-Verlag; 2006: 91-142 EK IV
• 271 Kröger B, Piontek D. Tabakentwöhnung in Deutschland. Grundlagen und kommentierte Übersicht. Gesundheitsförderung konkret. Band 2. Köln: Bundeszentrale für gesundheitliche Aufklärung (BZgA); EK IV 2011
• 272 Davies MJ, Heller S, Khunti K et al. The DESMOND educational intervention. Chronic lllness 2008; (01) 38-40 EK Ib
• 273 Hokanson JM, Anderson RL, Hennrikus DJ et al. Integrated tobacco cessation counseling in a diabetes self-management training program: a randomized trial of diabetes and reduction of tobacco. Diabetes Educ 2006; 32 (04) 562-570 EK Ib
• 274 Persson LG, Hjalmarson A. Smoking cessation in patients with diabetes mellitus: results from a controlled study of an intervention programme in primary healthcare in Sweden. Scand J Prim Health Care 2006; 24 (02) 75-80 EK IIa
• 275 Canga N, De Irala J, Vara E et al. Intervention study for smoking cessation in diabetic patients: a randomized controlled trial in both clinical and primary care settings. Diab Care 2000; 23 (10) 1455-1460 EK IIa
• 276 Eisenberg MJ, Filion KB, Yavin D et al. Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials. CMAJ 2008; 179 (02) 135-144 EK Ia
• 277 Stead LF, Perera R, Bullen C et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2008; 1: CD000146 EK Ia
• 278 Andreas S, Batra A, Behr J et al. Tabakentwöhnung bei COPD – S3 Leitlinie herausgegeben von der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin. Pneumologie 2008; 62 (05) 255-272 EK IV
• 279 Fiore MC, Jaén CR, Baker TB et al. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report. Am J Prev Med 2008; 35 (02) 158-176 EK IV
• 280 Parsons AC, Shraim M, Inglis J et al. Interventions for preventing weight gain after smoking cessation. Cochrane Database Syst Rev 2009; 1: CD006219 EK Ia
• 281 Häfner H, Maurer K, Ruhrmann S et al. Early detection and secondary prevention of psychosis: facts and visions. Eur Arch Psychiatry Clin Neurosci 2004; 254 (02) 117-128 EK IV
• 282 Gaebel W, Falkai P. S3-Praxisleitlinien in Psychiatrie und Psychotherapie. Band 1 Behandlungsleitlinie Schizophrenie. Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (Hrsg.). Darmstadt: Steinkopff-Verlag; 2006. EK IV
• 283 Myers KA, Edwards AL. Diabetic patients with psychiatric illness. Curr Diabetes Rev 2010; 6 (04) 222-227 EK IV
• 284 Osborn DP, Wright CA, Levy G et al. Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: systematic review and metaanalysis. BMC Psychiatry 2008; 8: 84 EK Ia
• 285 Reist C, Mintz J, Albers LJ et al. Second-generation antipsychotic exposure and metabolic-related disorders in patients with schizophrenia: an observational pharmacoepidemiology study from 1988 to 2002. J Clin Psychopharmacol 2007; 27 (01) 46-51 EK III
• 286 Cavazzoni P, Mukhopadhyay N, Carlson C et al. Retrospective analysis of risk factors in patients with treatment-emergent diabetes during clinical trials of antipsychotic medications. Br J Psychiatry 2004; 47: S94-S101 EK III
• 287 Ryan MC, Collins P, Thakore JH. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry 2003; 160 (02) 284-289 EK III
• 288 Hennekens CH. Increasing global burden of cardiovascular disease in general populations and patients with schizophrenia. J Clin Psychiatry 2007; 68 (Suppl. 04) 4-7 EK IV
• 289 ADA, APA, AACE et al. Consensus development conference on antipsychotic drugs and obesity and diabetes. J Clin Psychiatry 2004; 65 (02) 267-272 EK IV
• 290 Woo V, Harris SB, Houlden RN. Canadian Diabetes Association Position Paper: Antipsychotic medications and associated risks of weight gain and diabetes. Can J Diabetes 2005; 29 (02) 111-112 EK IV
• 291 Jennex A, Gardner DM. Monitoring and management of metabolic risk factors in outpatients taking antipsychotic drugs: a controlled study. Can J Psychiatry 2008; 53 (01) 34-42 EK III
• 292 Morrato EH, Newcomer JW, Kamat S et al. Metabolic screening after the American Diabetes Association’s consensus statement on antipsychotic drugs and diabetes. Diab Care 2009; 32 (06) 1037-1042 EK III
• 293 Simon V, van Winkel R, de Hert M. Are weight gain and metabolic side effects of atypical antipsychotics dose dependent? A literature review. J Clin Psychiatry 2009; 70 (07) 1041-1050 EK IV
• 294 Allison DB, Mentore JL, Heo M et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999; 156 (11) 1686-1696 EK IIa
• 295 Kahn RS, Fleischhacker WW, Boter H et al. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet 2008; 371 (9618) 1085-1097 EK Ib
• 296 Lieberman JA. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia: efficacy, safety and cost outcomes of CATIE and other trials. J Clin Psychiatry 2007; 68 (02) e04 EK Ib
• 297 Jin H, Meyer JM, Jeste DV. Atypical antipsychotics and glucose dysregulation: a systematic review. Schizophr Res 2004; 71 (02) 195-212 EK IV
• 298 Henderson DC, Cagliero E, Copeland PM et al. Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics. J Clin Psychiatry 2007; 68 (04) 533-541 EK III
• 299 Tiihonen J, Lönnqvist J, Wahlbeck K et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet 2009; 374 (9690) 620-627 EK III
• 300 Böhm BO, Dreyer M, Fritsche A et al. Therapie des Diabetes mellitus Typ 1. S3-Leitlinie herausgegeben von der Deutschen Diabetes-Gesellschaft. (http://www.deutsche-diabetes-gesellschaft.de/fileadmin/Redakteur/Leitlinien/Evidenzbasierte_Leitlinien/AktualisierungTherapieTyp1Diabetes_1_20120319_TL.pdf; zuletzt aufgerufen am 10.4.2013) EK IV
• 301 Matthaei S, Bierwirth R, Fritsche A et al. Medikamentöse antihyperglykämische Therapie des Diabetes mellitus Typ 2. Update der Evidenzbasierten Leitlinie der Deutschen Diabetes-Gesellschaft. Diabetologie und Stoffwechsel 2009; 4 (01) 32-64 EK IV
• 302 Mauri M, Simoncini M, Castrogiovanni S et al. A psychoeducational program for weight loss in patients who have experienced weight gain during antipsychotic treatment with olanzapine. Pharmacopsychiatry 2008; 41 (01) 17-23 EK Ib
• 303 Weber M, Wyne K. A cognitive/behavioral group intervention for weight loss in patients treated with atypical antipsychotics. Schizophr Res 2006; 83 (01) 95-101 EK Ib
• 304 McKibbin CL, Patterson TL, Norman G et al. A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial. Schizophr Res 2006; 86 (01) 36-44 EK Ib
• 305 McKibbin CL, Golshan S, Griver K et al. A healthy lifestyle intervention for middle-aged and older schizophrenia patients with diabetes mellitus: a 6-month follow-up analysis. Schizophr Res 2010; 121 (01) 203-206 EK Ib
• 306 Ehret M, Goethe J, Lanosa M et al. The effect of metformin on anthropometrics and insulin resistance in patients receiving atypical antipsychotic agents: a meta-analysis. J Clin Psychiatry 2010; 71 (10) 1286-1292 EK Ia
• 307 Anderson RJ, Freedland KE, Clouse RE et al. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diab Care 2001; 24 (06) 1069-1078 EK III
• 308 Huang CQ, Dong BR, Lu ZC et al. Chronic diseases and risk for depression in old age: a meta-analysis of published literature. Ageing Res Rev 2010; 9 (02) 131-141 EK Ib
• 309 Ali S, Stone MA, Peters JL et al. The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med 2006; 23 (11) 1165-1173 EK Ia
• 310 Barnard KD, Skinner TC, Peveler R. The prevalence of co-morbid depression in adults with Type 1 diabetes: systematic literature review. Diabet Med 2006; 23 (04) 445-448 EK Ia
• 311 Mezuk B, Eaton WW, Albrecht S et al. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diab Care 2008; 31 (12) 2383-2390 EK Ia
• 312 Chang-Quan H, Xue-Mei Z, Bi-Rong D et al. Health status and risk for depression among the elderly: a meta-analysis of published literature. Age Ageing 2010; 39 (01) 23-30 EK III
• 313 Icks A, Kruse J, Dragano N et al. Are symptoms of depression more common in diabetes? Results from the Heinz Nixdorf Recall study. Diabet Med 2008; 25 (11) 1330-1336 EK III
• 314 Petrak F, Hardt J, Wittchen HU et al. Prevalence of psychiatric disorders in an onset cohort of adults with type 1 diabetes. Diabetes Metab Res Rev 2003; 19 (03) 216-222 EK III
• 315 Hermanns N, Kulzer B, Krichbaum M et al. Affective and anxiety disorders in a German sample of diabetic patients: prevalence, comorbidity and risk factors. Diabet Med 2005; 22 (03) 293-300 EK III
• 316 Knol MJ, Twisk JW, Beekman AT et al. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 2006; 49 (05) 837-845 EK Ia
• 317 Cosgrove MP, Sargeant LA, Griffin SJ. Does depression increase the risk of developing type 2 diabetes?. Occup Med 2008; 58 (01) 7-14 EK Ia
• 318 Nouwen A, Winkley K, Twisk J et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia 2010; 53 (12) 2480-2486 EK Ia
• 319 De Groot M, Anderson R, Freedland KE et al. Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001; 63 (04) 619-630 EK III
• 320 Pouwer F, Beekman AT, Nijpels G et al. Rates and risks for co-morbid depression in patients with Type 2 diabetes mellitus: results from a community-based study. Diabetologia 2003; 46 (07) 892-898 EK III
• 321 Peyrot M, Rubin RR. Persistence of depressive symptoms in diabetic adults. Diab Care 1999; 22 (03) 448-452 EK III
• 322 Goldney RD, Phillips PJ, Fisher LJ et al. Diabetes, depression, and quality of life: a population study. Diab Care 2004; 27 (05) 1066-1070 EK III
• 323 Schram MT, Baan CA, Pouwer F. Depression and quality of life in patients with diabetes: a systematic review from the European depression in diabetes (EDID) research consortium. Curr Diabetes Rev 2009; 5 (02) 112-119 EK III
• 324 Ali S, Stone M, Skinner TC et al. The association between depression and health-related quality of life in people with type 2 diabetes: a systematic literature review. Diabetes Metab Res Rev 2010; 26 (02) 75-89 EK Ia
• 325 Egede LE. Diabetes, Major Depression, and Functional Disability among U.S. Adults. Diab Care 2004; 27 (02) 421-428 EK III
• 326 Gregg EW, Mangione CM, Cauley JA et al. Diabetes and incidence of functional disability in older women. Diab Care 2002; 25 (01) 61-67 EK III
• 327 Bruce DG, Davis WA, Starkstein SE et al. A prospective study of depression and mortality in patients with type 2 diabetes: the Fremantle Diabetes Study. Diabetologia 2005; 48 (12) 2532-2539 EK III
• 328 Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000; 160 (21) 3278-3285 EK III
• 329 Egede LE, Zheng D, Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diab Care 2002; 25 (03) 464-470 EK III
• 330 Simon GE, Katon WJ, Lin EH et al. Diabetes complications and depression as predictors of health service costs. Gen Hosp Psychiatry 2005; 27 (05) 344-351 EK III
• 331 Black SA, Markides KS, Ray LA. Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diab Care 2003; 26 (10) 2822-2828 EK III
• 332 Katon WJ, Von Korff M, Lin EH et al. The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry 2004; 61 (10) 1042-1049 EK Ib
• 333 Zhang X, Norris SL, Gregg EW et al. Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol 2005; 161 (07) 652-660 EK III
• 334 Katon W, Fan MY, Unutzer J et al. Depression and diabetes: a potentially lethal combination. J Gen Intern Med 2008; 23 (10) 1571-1575 EK III
• 335 Richardson LK, Egede LE, Mueller M et al. Longitudinal effects of depression on glycemic control in veterans with Type 2 diabetes. Gen Hosp Psychiatry 2008; 30 (06) 509-514 EK III
• 336 Young BA, Von Korff M, Heckbert SR et al. Association of major depression and mortality in Stage 5 diabetic chronic kidney disease. Gen Hosp Psychiatry 2010; 32 (02) 119-124 EK III
• 337 Lustman PJ, Anderson RJ, Freedland KE et al. Depression and poor glycemic control: a meta-analytic review of the literature. Diab Care 2000; 23 (07) 934-942 EK III
• 338 Pouwer F, Snoek FJ. Association between symptoms of depression and glycaemic control may be unstable across gender. Diabet Med 2001; 18 (07) 595-598 EK III
• 339 Gonzalez JS, Peyrot M, McCarl LA et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diab Care 2008; 31 (12) 2398-2403 EK IIb
• 340 Gonzalez JS, Safren SA, Delahanty LM et al. Symptoms of depression prospectively predict poorer self-care in patients with Type 2 diabetes. Diabet Med 2008; 25 (09) 1102-1107 EK III
• 341 Marcus MD, Wing RR, Guare J et al. Lifetime prevalence of major depression and its effect on treatment outcome in obese type II diabetic patients. Diab Care 1992; 15 (02) 253-255 EK III
• 342 Rubin RR, Gaussoin SA, Peyrot M et al. Cardiovascular disease risk factors, depression symptoms and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes. Diabetologia 2010; 53 (08) 1581-1589 EK III
• 343 Wolkowitz OM, Reus VI, Mellon SH. Of sound mind and body: depression, disease, and accelerated aging. Dialogues Clin Neurosci 2011; 13 (01) 25-39 EK III
• 344 Stuart MJ, Baune BT. Depression and type 2 diabetes: inflammatory mechanisms of a psychoneuroendocrine co-morbidity. Neurosci Biobehav Rev 2012; 36 (01) 658-676 EK III
• 345 Hermanns N, Kulzer B, Krichbaum M et al. How to screen for depression and emotional problems in patients with diabetes: comparison of screening characteristics of depression questionnaires, measurement of diabetes-specific emotional problems and standard clinical assessment. Diabetologia 2006; 49 (03) 469-477 EK III
• 346 Pouwer F, Beekman AT, Lubach C et al. Nurses’ recognition and registration of depression, anxiety and diabetes-specific emotional problems in outpatients with diabetes mellitus. Patient Educ Couns 2006; 60 (02) 235-240 EK III
• 347 Rubin RR, Ciechanowski P, Egede LE et al. Recognizing and treating depression in patients with diabetes. Current Diabetes Reports 2004; 4 (02) 119-125 EK IV
• 348 Whooley MA, Avins AL, Miranda J et al. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med 1997; 12 (07) 439-445 EK III
• 349 Arroll B, Khin N, Kerse N. Screening for depression in primary care with two verbally asked questions: cross sectional study. BMJ 2003; 327 (7424) 1144-1146 EK III
• 350 Arroll B, Goodyear-Smith F, Kerse N et al. Effect of the addition of a “help” question to two screening questions on specificity for diagnosis of depression in general practice: diagnostic validity study. BMJ 2005; 331: 884 EK III
• 351 Hautzinger M, Bailer J, Hofmeister D et al. ADS. Allgemeine Depressions-Skala. 2. Aufl. Göttingen: Hogrefe; 2012
• 352 Hautzinger M, Keller F, Kühner C. Beck Depressions-Inventar (BDI-II). Revision. Frankfurt/Main: Harcourt Test Services; 2006
• 353 Herrmann-Lingen C, Buss U, Snaith RP. HADS-D. Hospital Anxiety and Depression Scale – Deutsche Version. 3. aktualisierte Aufl. Bern: Huber; 2011
• 354 Gräfe K, Zipfel S, Herzog W et al. Screening psychischer Störungen mit dem „Gesundheitsfragebogen für Patienten (PHQ-D)“. Ergebnisse der deutschen Validierungsstudie. Diagnostica 2004; 50 (04) 171-181
• 355 Roy T, Lloyd CE, Pouwer F et al. Screening tools used for measuring depression among people with Type 1 and Type 2 diabetes: a systematic review. Diabet Med 2012; 29 (02) 164-175 EK III
• 356 DGPPN, BÄK, KBV, AWMF et al. S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression – Langfassung. 2012 http://www.versorgungsleitlinien.de/themen/depression/pdf/s3_nvl_depression_lang.pdf zuletzt aufgerufen am 10.4.2013. EK IV
• 357 Fisher L, Skaff MM, Mullan JT et al. A longitudinal study of affective and anxiety disorders, depressive affect and diabetes distress in adults with Type 2 diabetes. Diabet Med 2008; 25 (09) 1096-1101 EK III
• 358 Fisher L, Glasgow RE, Strycker LA. The relationship between diabetes distress and clinical depression with glycemic control among patients with type 2 diabetes. Diab Care 2010; 33 (05) 1034-1036 EK III
• 359 Harris EC, Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry 1997; 170: 205-228 EK III
• 360 Harris EC, Barraclough B. Excess mortality of mental disorder. Br J Psychiatry 1998; 173: 11-53 EK III
• 361 Brieger P, Marneros A. Komorbidität bei psychiatrischen Krankheiten Einige theoretische Überlegungen. Nervenarzt 2000; 71 (07) 525-534 EK IV
• 362 Pouwer F. Should we screen for emotional distress in type 2 diabetes mellitus?. Nat Rev Endocrinol 2009; 5 (12) 665-671 EK IV
• 363 Pouwer F, Tack CJ, Geelhoed-Duijvestijn PH et al. Limited effect of screening for depression with written feedback in outpatients with diabetes mellitus: a randomised controlled trial. Diabetologia 2011; 54 (04) 741-748 EK Ib
• 364 van der Feltz-Cornelis CM, Nuyen J, Stoop C et al. Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis. Gen Hosp Psychiatry 2010; 32 (04) 380-395 EK Ia
• 365 van Bastelaar KM, Pouwer F, Cuijpers P et al. Web-based depression treatment for type 1 and type 2 diabetic patients: a randomized, controlled trial. Diab Care 2011; 34 (02) 320-325 EK Ib
• 366 Lustman PJ, Griffith LS, Clouse RE et al. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med 1997; 59 (03) 241-250 EK Ib
• 367 Goodnick PJ, Kumar A, Henry JH et al. Sertraline in coexisting major depression and diabetes mellitus. Psychopharmacol Bull 33 (02) 261-264 EK IIb
• 368 David S. [SSRI should be considered as the cause of hypoglycemias which are difficult to explain]. Lakartidningen 2005; 102 (08) 582 EK IV
• 369 Derijks HJ, Heerdink ER, De Koning FH et al. The association between antidepressant use and hypoglycaemia in diabetic patients: a nested case-control study. Pharmacoepidemioloy and Drug Safety 2008; 17 (04) 336-344 EK IV
• 370 Derijks HJ, Meyboom RH, Heerdink ER et al. The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports. Eur J Clin Pharmacol 2008; 64 (05) 531-538 EK IV
• 371 Goldstein DJ, Lu Y, Detke MJ et al. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005; 116 (01) 109-118 EK IV
• 372 Perahia DG, Kajdasz DK, Royer MG et al. Duloxetine in the treatment of major depressive disorder: an assessment of the relationship between outcomes and episode characteristics. Int Clin Psychopharmacol 2006; 21 (05) 285-295 EK III
• 373 Perahia DG, Pritchett YL, Desaiah D et al. Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?. Int Clin Psychopharmacol 2006; 21 (06) 311-317 EK III
• 374 Kubiak T, Weik A, Kulzer B, Hermanns N. Behandlung psychischer Störungen bei Diabetes mellitus. In: Härter M, Baumeister H, Bengel J, (Hrsg.). Psychische Störungen bei körperlichen Erkrankungen. Springer: Heidelberg; 2007: 111-123 EK III
• 375 Boulton AJ, Vinik AI, Arezzo JC et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diab Care 2005; 28 (04) 956-962 EK IV
• 376 Bogner HR, de Vries HF. Integrating type 2 diabetes mellitus and depression treatment among african americans: a randomized controlled pilot trial. Diabetes Educ 2010; 36 (02) 284-292 EK Ib
• 377 Ell K, Katon W, Xie B et al. Collaborative care management of major depression among low-income, predominantly Hispanic subjects with diabetes: a randomized controlled trial. Diab Care 2010; 33 (04) 706-713 EK Ib
• 378 Ell K, Aranda MP, Xie B et al. Collaborative depression treatment in older and younger adults with physical illness: pooled comparative analysis of three randomized clinical trials. Am J Geriatr Psychiatry 2010; 18 (06) 520-530 EK Ib
• 379 Katon WJ, Lin EH, Von Korff M et al. Collaborative care for patients with depression and chronic illnesses. NEJM 2010; 363 (27) 2611-2620 EK Ib
• 380 Williams JW Jr, Katon W, Lin EH et al. The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann Intern Med 2004; 140 (12) 1015-1024 EK Ib
• 381 Herring MP, Puetz TW, O’Connor PJ et al. Effect of exercise training on depressive symptoms among patients with a chronic illness: a systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 2012; 172 (02) 101-111 EK Ia
• 382 Wittchen HU, Muller N, Pfister H et al. Affective, somatoform and anxiety disorders in Germany – initial results of an additional federal survey of “psychiatric disorders”. Gesundheitswesen 1999; 61: S216-S222 EK III
• 383 Meyer C, Rumpf HJ, Hapke U et al. Lebenszeitprävalenz psychischer Störungen in der erwachsenen Allgemeinbevölkerung Ergebnisse der TACOS-Studie. Nervenarzt 2000; 71 (07) 535-542 EK III
• 384 Li C, Barker L, Ford ES et al. Diabetes and anxiety in US adults: findings from the 2006 Behavioral Risk Factor Surveillance System. Diabet Med 2008; 25 (07) 878-881 EK III
• 385 Lin EH, Korff MV, Alonso J et al. Mental disorders among persons with diabetes – results from the World Mental Health Surveys. Journal of Psychosomatic Research 2008; 65 (06) 571-580 EK III
• 386 Berlin I, Bisserbe JC, Eiber R et al. Phobic symptoms, particularly the fear of blood and injury, are associated with poor glycemic control in type I diabetic adults. Diab Care 1997; 20 (02) 176-178 EK III
• 387 Grigsby AB, Anderson RJ, Freedland KE et al. Prevalence of anxiety in adults with diabetes: a systematic review. J Psychosom Res 2002; 53 (06) 1053-1060 EK III
• 388 Collins MM, Corcoran P, Perry IJ. Anxiety and depression symptoms in patients with diabetes. Diabet Med 2009; 26 (02) 153-161 EK III
• 389 Lloyd CE, Dyer PH, Barnett AH. Prevalence of symptoms of depression and anxiety in a diabetes clinic population. Diabet Med 2000; 17 (03) 198-202 EK III
• 390 Wu SF, Huang YC, Liang SY et al. Relationships among depression, anxiety, self-care behaviour and diabetes education difficulties in patients with type-2 diabetes: a cross-sectional questionnaire survey. Int J Nurs Stud 2011; 48 (11) 1376-1383 EK III
• 391 Labad J, Price JF, Strachan MW et al. Symptoms of depression but not anxiety are associated with central obesity and cardiovascular disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetologia 2010; 53 (03) 467-471 EK III
• 392 Duran-Atzinger G. Alltagsbelastungen bei Patienten mit Diabetes mellitus. Regensburg: 1992. EK III
• 393 Snoek FJ, Pouwer F, Welch GW et al. Diabetes-related emotional distress in Dutch and U.S. diabetic patients: cross-cultural validity of the problem areas in diabetes scale. Diab Care 2000; 23 (09) 1305-1309 EK III
• 394 Welch GW, Jacobson AM, Polonsky WH. The Problem Areas in Diabetes Scale. An evaluation of its clinical utility. Diab Care 1997; 20 (05) 760-766 EK III
• 395 Mollema ED, Snoek FJ, Ader HJ et al. Insulin-treated diabetes patients with fear of self-injecting or fear of self-testing: psychological comorbidity and general well-being. J Psychosom Res 2001; 51 (05) 665-672 EK III
• 396 Petrak F, Stridde E, Leverkus F et al. Development and validation of a new measure to evaluate psychological resistance to insulin treatment. Diab Care 2007; 30 (09) 2199-2204 EK III
• 397 Snoek FJ, Mollema ED, Heine RJ et al. Development and validation of the diabetes fear of injecting and self-testing questionnaire (D-FISQ): first findings. Diabet Med 1997; 14 (10) 871-876 EK III
• 398 Mollema ED, Snoek FJ, Heine RJ et al. Phobia of self-injecting and self-testing in insulin-treated diabetes patients: opportunities for screening. Diabet Med 2001; 18 (08) 671-674 EK III
• 399 Zambanini A, Newson RB, Maisey M et al. Injection related anxiety in insulin-treated diabetes. Diabetes Res Clin Pract 1999; 46 (03) 239-246 EK III
• 400 Peyrot M, Rubin RR, Lauritzen T et al. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diab Care 2005; 28 (11) 2673-2679 EK III
• 401 Brod M, Kongso JH, Lessard S et al. Psychological insulin resistance: patient beliefs and implications for diabetes management. Qual Life Res 2009; 18 (01) 23-32 EK IV
• 402 Meece J. Dispelling myths and removing barriers about insulin in type 2 diabetes. Diabetes Educ 2006; 32 (Suppl. 01) 9S-18S EK IV
• 403 Nam S, Chesla C, Stotts NA et al. Factors associated with psychological insulin resistance in individuals with type 2 diabetes. Diab Care 2010; 33 (08) 1747-1749 EK III
• 404 Petrak F. Psychologische Barrieren der Insulintherapie bei Patienten mit Typ-2-Diabetes. Diabetes, Stoffwechsel und Herz 2006; 15: 28-34 EK III
• 405 Petrak F, Joschko A, Kaltheuner M et al. Psychische Belastungen und Therapieadhärenz von Patienten mit Diabetes in diabetologischen Schwerpunktpraxen. Diabetes, Stoffwechsel und Herz 2011; 20: 7-14 EK III
• 406 Hummel J, Kuhner C, Kopf D et al. Psychosocial barriers to starting insulin therapy in type 2 diabetes mellitus. Diabetes Res Clin Pract 2008; 82 (03) e25-e26 EK III
• 407 Kohen D, Burgess AP, Catalan J et al. The role of anxiety and depression in quality of life and symptom reporting in people with diabetes mellitus. Qual Life Res 1998; 7 (03) 197-204 EK III
• 408 Fu AZ, Qiu Y, Radican L. Impact of fear of insulin or fear of injection on treatment outcomes of patients with diabetes. Curr Med Res Opin 2009; 25 (06) 1413-1420 EK III
• 409 National Collaborating Centre for Mental Health (UK). Generalised Anxiety Disorder in Adults: Management in Primary, Secondary and Community Care. (NICE Clinical Guidelines, No. 113). Leicester: British Psychological Society; 2011. EK IV
• 410 Kulzer B. Angst vor Unterzuckerungen. In: Kohlmann CW, Kulzer B, (Hrsg.). Diabetes und Psychologie. 1995: 64-80
• 411 Löwe B, Spitzer RL, Zipfel S et al. PHQ-D. Gesundheitsfragebogen für Patienten. Autorisierte deutsche Version des „Prime MD Patient Health Questionnaire (PHQ)“. 2. Aufl. Karlsruhe: Pfizer; 2002
• 412 Margrarf J. Diagnostisches Kurzinterview für psychische Störungen (Mini-DIPS). Berlin: Springer; 1994
• 413 Dengler W, Selbmann H. Leitlinien zur Diagnostik und Therapie von Angsterkrankungen. Darmstadt: Steinkopff; 2001. EK IV
• 414 Culpepper L. Generalized anxiety disorder and medical illness. J Clin Psychiatry 2009; 70 (Suppl. 02) 20-24 EK IV
• 415 Carter RM, Wittchen HU, Pfister H et al. One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample. Depress Anxiety 2001; 13 (02) 78-88 EK III
• 416 Kessler RC, Chiu WT, Demler O et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62 (06) 617-627 EK III
• 417 Bell DS, Christian ST, Clements RS et al. Acuphobia in a long-standing insulin-dependent diabetic patient cured by hypnosis. Diab Care 1983; 6 (06) 622 EK IV
• 418 Kolko DJ, Milan MA. Misconception correction through reading in the treatment of a self-injection phobia. J Behav Ther Exp Psychiatry 1980; 11 (04) 273-276 EK IV
• 419 Steel J, Taylor R, Lloyd G. Behaviour therapy for phobia of venepuncture. Diabet Med 1986; 3 (05) 481 EK IV
• 420 Zambanini A, Feher MD. Needle phobia in type 1 diabetes mellitus. Diabet Med 1997; 14 (04) 321-323 EK IV
• 421 Fröhlich C, Zettler A, Reinecker H et al. Evaluation eines Gruppentrainings zur Verbesserung der Hypoglykämiewahrnehmung (WT) und Angstbewältigung (AT). Praxis der Klinischen Verhaltensmedizin und Rehabilitation 1992; 17 (05) 30-34 EK IIa
• 422 Cox DJ, Gonder-Frederick L, Polonsky W et al. Blood glucose awareness training (BGAT-2): long-term benefits. Diab Care 2001; 24 (04) 637-642 EK IIb
• 423 Zettler A, Duran G, Waadt S et al. Coping with fear of long-term complications in diabetes mellitus: a model clinical program. Psychother Psychosom 1995; 64 (03) 178-184 EK IIb
• 424 Sanchez-Meca J, Rosa-Alcazar AI, Marin-Martinez F et al. Psychological treatment of panic disorder with or without agoraphobia: a meta-analysis. Clin Psychol Rev 2010; 30 (01) 37-50 EK Ia
• 425 Wolitzky-Taylor KB, Horowitz JD, Powers MB et al. Psychological approaches in the treatment of specific phobias: a meta-analysis. Clin Psychol Rev 2008; 28 (06) 1021-1037 EK Ia
• 426 Siev J, Chambless DL. Specificity of treatment effects: cognitive therapy and relaxation for generalized anxiety and panic disorders. J Consult Clin Psychol 2007; 75 (04) 513-522 EK Ia
• 427 Spek V, Cuijpers P, Nyklicek I et al. Internet-based cognitive behaviour therapy for symptoms of depression and anxiety: a meta-analysis. Psychol Med 2007; 37 (03) 319-328 EK Ia
• 428 Furukawa TA, Watanabe N, Churchill R. Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: systematic review. Br J Psychiatry 2006; 188: 305-312 EK Ia
• 429 Mitte K, Noack P, Steil R et al. A meta-analytic review of the efficacy of drug treatment in generalized anxiety disorder. J Clin Psychopharmacol 2005; 25 (02) 141-150 EK Ia
• 430 Bakker A, van Balkom AJ, Spinhoven P. SSRIs vs. TCAs in the treatment of panic disorder: a meta-analysis. Acta Psychiatr Scand 2002; 106 (03) 163-167 EK Ia
• 431 APA – American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. DSM-IV-TR (4th edition, Text Revision). American Psychiatric Association, Washington, DC; 2003. [deutsch: Saß H, Wittchen HU, Zaudig M (Hrsg.) Diagnostisches und Statistisches Manual Psychischer Störungen. DSM-IV-TR. (4. Aufl., Textrevision.) Göttingen: Hogrefe; 2003
• 432 Stunkard AJ, GRACE WJ, Wolff HG. The night-eating syndrome: A pattern of food intake among certain obese patients. The American Journal of Medicine 1955; 19 (01) 78-86 EK IV
• 433 Mühlhans B, Olbrich K, de Zwaan M. Night Eating Syndrom und nächtliches Essen – was ist das eigentlich?. Psychother Psychosom Med Psychol 2009; 59 (02) 50-56 EK IV
• 434 DGPM, DKMP, DGKJP et al. S3-Leitlinie. Diagnostik und Therapie der Essstörungen. 2010 http://www.awmf.org/uploads/tx_szleitlinien/051-026l_S3_Diagnostik_Therapie_Essstörungen.pdf zuletzt aufgerufen am 18.12.2012. EK IV
• 435 O’Brien KM, Vincent NK. Psychiatric comorbidity in anorexia and bulimia nervosa: nature, prevalence, and causal relationships. Clin Psychol Rev 2003; 23 (01) 57-74 EK III
• 436 Bornstein RF. A Meta-Analysis of the Dependency-Eating-Disorders Relationship: Strength, Specificity, and Temporal Stability. Journal of Psychopathology and Behavioral Assessment 2001; 23 (03) 151-162 EK Ib
• 437 Cassin SE, von Ranson KM. Personality and eating disorders: a decade in review. Clin Psychol Rev 2005; 25 (07) 895-916 EK III
• 438 Neumark-Sztainer D, Patterson J, Mellin A et al. Weight control practices and disordered eating behaviors among adolescent females and males with type 1 diabetes: associations with sociodemographics, weight concerns, familial factors, and metabolic outcomes. Diab Care 2002; 25 (08) 1289-1296 EK III
• 439 Helgeson VS, Siminerio L, Escobar O et al. Predictors of metabolic control among adolescents with diabetes: a 4-year longitudinal study. J Pediatr Psychol 2009; 34 (03) 254-270 EK IIb
• 440 Grylli V, Hafferl-Gattermayer A, Schober E et al. Prevalence and clinical manifestations of eating disorders in Austrian adolescents with type-1 diabetes. Wien Klin Wochenschr 2004; 116 (07) 230-234 EK IIb
• 441 Engström I, Kroon M, Arvidsson CG et al. Eating disorders in adolescent girls with insulin-dependent diabetes mellitus: a population-based case-control study. Acta Paediatr 1999; 88 (02) 175-180 EK IIa
• 442 Jones JM, Lawson ML, Daneman D et al. Eating disorders in adolescent females with and without type 1 diabetes: cross sectional study. BMJ 2000; 320 (7249) 1563-1566 EK IIa
• 443 Alice HsuYY, Chen BH, Huang MC et al. Disturbed eating behaviors in Taiwanese adolescents with type 1 diabetes mellitus: a comparative study. Pediatr Diabetes 2009; 10 (01) 74-81 EK III
• 444 Colton P, Olmsted M, Daneman D et al. Disturbed eating behavior and eating disorders in preteen and early teenage girls with type 1 diabetes: a case-controlled study. Diab Care 2004; 27 (07) 1654-1659 EK III
• 445 Olmsted MP, Daneman D, Rydall AC et al. The effects of psychoeducation on disturbed eating attitudes and behavior in young women with type 1 diabetes mellitus. Int J Eat Disord 2002; 32 (02) 230-239 EK III
• 446 Fairburn CG, Peveler RC, Davies B et al. Eating disorders in young adults with insulin dependent diabetes mellitus: a controlled study. BMJ 1991; 303 (6793) 17-20 EK IIa
• 447 Peveler RC, Fairburn CG, Boller I et al. Eating disorders in adolescents with IDDM. A controlled study. Diab Care 1992; 15 (10) 1356-1360 EK IIa
• 448 Striegel-Moore RH, Nicholson TJ, Tamborlane WV. Prevalence of eating disorder symptoms in preadolescent and adolescent girls with IDDM. Diab Care 1992; 15 (10) 1361-1368 EK IIa
• 449 Nielsen S, Mølbak AG. Eating disorder and type 1 diabetes: overview and summing-up. Eur Eat Disorders Rev 1998; 6 (01) 4-26 EK Ia
• 450 Morse SA, Ciechanowski PS, Katon WJ et al. Isn’t this just bedtime snacking? The potential adverse effects of night-eating symptoms on treatment adherence and outcomes in patients with diabetes. Diab Care 2006; 29 (08) 1800-1804 EK III
• 451 Mannucci E, Rotella F, Ricca V et al. Eating disorders in patients with type 1 diabetes: a meta-analysis. J Endocrinol Invest 2005; 28 (05) 417-419 EK Ib
• 452 Crow S, Kendall D, Praus B et al. Binge eating and other psychopathology in patients with type II diabetes mellitus. Int J Eat Disord 2001; 30 (02) 222-226 EK IIb
• 453 Papelbaum M, Appolinario JC, Moreira RO et al. Prevalence of eating disorders and psychiatric comorbidity in a clinical sample of type 2 diabetes mellitus patients. Rev Bras Psiquiatr 2005; 27 (02) 135-138 EK III
• 454 Kenardy J, Mensch M, Bowen K et al. A comparison of eating behaviors in newly diagnosed NIDDM patients and case-matched control subjects. Diab Care 1994; 17 (10) 1197-1199 EK IIa
• 455 Allison KC, Crow SJ, Reeves RR et al. Binge eating disorder and night eating syndrome in adults with type 2 diabetes. Obesity (Silver Spring) 2007; 15 (05) 1287-1293 EK IIb
• 456 Gorin AA, Niemeier HM, Hogan P et al. Binge eating and weight loss outcomes in overweight and obese individuals with type 2 diabetes: results from the Look AHEAD trial. Arch Gen Psychiatry 2008; 65 (12) 1447-1455 EK IIb
• 457 Herpertz S, Albus C, Wagener R et al. Comorbidity of diabetes and eating disorders. Does diabetes control reflect disturbed eating behavior?. Diab Care 1998; 21 (07) 1110-1116 EK III
• 458 Stancin T, Link DL, Reuter JM. Binge eating and purging in young women with IDDM. Diab Care 1989; 12 (09) 601-603 EK III
• 459 Rydall AC, Rodin GM, Olmsted MP et al. Disordered eating behavior and microvascular complications in young women with insulin-dependent diabetes mellitus. NEJM 1997; 336 (26) 1849-1854 EK IIa
• 460 Goebel-Fabbri AE, Fikkan J, Connell A et al. Identification and treatment of eating disorders in women with type 1 diabetes mellitus. Treat Endocrinol 2002; 1 (03) 155-162 EK III
• 461 de Beaufort CE, Swift PG, Skinner CT et al. Continuing stability of center differences in pediatric diabetes care: do advances in diabetes treatment improve outcome? The Hvidoere Study Group on Childhood Diabetes. Diab Care 2007; 30 (09) 2245-2250 EK III
• 462 Takii M, Uchigata Y, Tokunaga S et al. The duration of severe insulin omission is the factor most closely associated with the microvascular complications of Type 1 diabetic females with clinical eating disorders. Int J Eat Disord 2008; 41 (03) 259-264 EK IIb
• 463 Nielsen S, Emborg C, Molbak AG. Mortality in concurrent type 1 diabetes and anorexia nervosa. Diab Care 2002; 25 (02) 309-312 EK IIb
• 464 Herpertz S, Herpertz-Dahlmann B, Fichter M et al. S3-Leitlinie. Diagnostik und Behandlung der Essstörungen. 1. Aufl. Berlin: Springer; 2011. EK IV
• 465 Bahrke U, Bandemer-Greulich U, Fikentscher E et al. Erfassung essgestörten Verhaltens bei Patientinnen mit Diabetes mellitus mit Hilfe eines Fragebogens (Diab-Ess). Diabetologie und Stoffwechsel 2006; 1 (01) 46-53
• 466 Feiereis H. Diabetes mellitus Typ I und Bulimie – eine bedrohliche Doppelkrankheit. Dtsch Med Wochenschr 1988; 113 (48) 1876-1878 EK IV
• 467 Peveler RC, Fairburn CG. Anorexia nervosa in association with diabetes mellitus – a cognitive-behavioral approach to treatment. Behaviour Research and Therapy 1989; 27: 95-99 EK IV
• 468 Herpertz S, von Blume B, Senf W. Essstörungen und Diabetes mellitus. Z Psychosom Med Psychoanal 1995; 41 (04) 329-343 EK IV
• 469 Takii M, Uchigata Y, Komaki G et al. An integrated inpatient therapy for type 1 diabetic females with bulimia nervosa: a 3-year follow-up study. J Psychosom Res 2003; 55 (04) 349-356 EK IIb
• 470 Daneman D, Rodin G, Jones J et al. Eating Disorders in Adolescent Girls and Young Adult Women With Type 1 Diabetes. Diabetes Spectr 2002; 15 (02) 83-105 EK IV
• 471 Kenardy J, Mensch M, Bowen K et al. Group therapy for binge eating in Type 2 diabetes: a randomized trial. Diabet Med 2002; 19 (03) 234-239 EK IIa
• 472 Osterberg L, Blaschke T. Adherence to medication. NEJM 2005; 353 (05) 487-497 EK IV
• 473 Blaschke TF, Osterberg L, Vrijens B et al. Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. Annu Rev Pharmacol Toxicol 2012; 52: 275-301 EK IV
• 474 Pouwer F, Kupper N, Adriaanse MC. Does emotional stress cause type 2 diabetes mellitus? A review from the European Depression in Diabetes (EDID) Research Consortium. Discov Med 2010; 9 (45) 112-118 EK III
• 475 Chida Y, Hamer M. An association of adverse psychosocial factors with diabetes mellitus: a meta-analytic review of longitudinal cohort studies. Diabetologia 2008; 51 (12) 2168-2178 EK III
• 476 Polonsky WH, Anderson BJ, Lohrer PA et al. Assessment of diabetes-related distress. Diab Care 1995; 18 (06) 754-760 EK III
• 477 Odegard PS, Gray SL. Barriers to medication adherence in poorly controlled diabetes mellitus. Diabetes Educ 2008; 34 (04) 692-697 EK III
• 478 Schmittdiel JA, Uratsu CS, Karter AJ et al. Why don’t diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med 2008; 23 (05) 588-594 EK III
• 479 Kubiak T, Hermanns N, Kulzer B et al. Evaluation der deutschen Fassung des Problem Areas in Diabetes (PAID) Fragebogens. In: Helmes A, (Hrsg.). Lebensstiländerungen in der Prävention und Rehabilitation. Lengerich: Papst; 2005: 151 EK III
• 480 Soo H, Lam S. Stress management training in diabetes mellitus. J Health Psychol 2009; 14 (07) 933-943 EK Ib
• 481 Walker EA, Usher JA. Understanding and enhancing adherence in adults with diabetes. Curr Diab Rep 2003; 3 (02) 141-148 EK Ib
• 482 Alam R, Sturt J, Lall R et al. An updated meta-analysis to assess the effectiveness of psychological interventions delivered by psychological specialists and generalist clinicians on glycaemic control and on psychological status. Patient Educ Couns 2009; 75 (01) 25-36 EK Ia
• 483 Winkley K, Ismail K, Landau S et al. Psychological interventions to improve glycaemic control in patients with type 1 diabetes: systematic review and meta-analysis of randomised controlled trials. BMJ 2006; 333 (7558) 65 EK Ia
• 484 Henry JL, Wilson PH, Bruce DG et al. Cognitive-behavioural stress management for patients with non-insulin dependent diabetes mellitus. Psychology, Health & Medicine 1997; 2 (02) 109-118 EK Ib
• 485 McGinnis RA, McGrady A, Cox SA et al. Biofeedback-assisted relaxation in type 2 diabetes. Diab Care 2005; 28 (09) 2145-2149 EK Ib
• 486 Surwit RS, van Tilburg MA, Zucker N et al. Stress management improves long-term glycemic control in type 2 diabetes. Diab Care 2002; 25 (01) 30-34 EK Ib
• 487 Tsujiuchi T, Kumano H, Yoshiuchi K et al. The effect of Qi-gong relaxation exercise on the control of type 2 diabetes mellitus: a randomized controlled trial. Diab Care 2002; 25 (01) 241-242 EK Ib
• 488 Attari A, Sartippour M, Amini M et al. Effect of stress management training on glycemic control in patients with type 1 diabetes. Diabetes Res Clin Pract 2006; 73 (01) 23-28 EK IIa
• 489 Feinglos MN, Hastedt P, Surwit RS. Effects of relaxation therapy on patients with type I diabetes mellitus. Diab Care 1987; 10 (01) 72-75 EK Ib
• 490 Jablon SL, Naliboff BD, Gilmore SL et al. Effects of relaxation training on glucose tolerance and diabetic control in type II diabetes. Appl Psychophysiol Biofeedback 1997; 22 (03) 155-169 EK Ib
• 491 Stenström U, Göth A, Carlsson C et al. Stress management training as related to glycemic control and mood in adults with Type 1 diabetes mellitus. Diabetes Res Clin Pract 2003; 60 (03) 147-152 EK Ib
• 492 van Rooijen AJ, Rheeder P, Eales CJ et al. Effect of exercise versus relaxation on haemoglobin A1C in Black females with type 2 diabetes mellitus. QJM 2004; 97 (06) 343-351 EK Ib
• 493 Aikens JE, Kiolbasa TA, Sobel R. Psychological predictors of glycemic change with relaxation training in non-insulin-dependent diabetes mellitus. Psychother Psychosom 1997; 66 (06) 302-306 EK IIa
• 494 Whalley B, Rees K, Davies P et al. Psychological interventions for coronary heart disease. Cochrane Database Syst Rev 2011; (08) CD002902 EK Ia
• 495 Fosbury JA, Bosley CM, Ryle A et al. A trial of cognitive analytic therapy in poorly controlled type I patients. Diab Care 1997; 20 (06) 959-964 EK Ib
• 496 Stevens LC. Programs and meta-programs for the control of diabetic symptomatology: A comparative treatment study. Denton, Texas, USA: North Texas State University; 1983. EK IIa
• 497 van Dam HA, van der Horst FG, Knoops L et al. Social support in diabetes: a systematic review of controlled intervention studies. Patient Educ Couns 2005; 59 (01) 1-12 EK Ib
• 498 Anderson RM, Funnell MM, Butler PM et al. Patient empowerment. Results of a randomized controlled trial. Diab Care 1995; 18 (07) 943-949 EK Ib
• 499 Ismail K, Thomas SM, Maissi E et al. Motivational enhancement therapy with and without cognitive behavior therapy to treat type 1 diabetes: a randomized trial. Ann Intern Med 2008; 149 (10) 708-719 EK Ib
• 500 Karlsen B, Idsoe T, Dirdal I et al. Effects of a group-based counselling programme on diabetes-related stress, coping, psychological well-being and metabolic control in adults with type 1 or type 2 diabetes. Patient Educ Couns 2004; 53 (03) 299-308 EK Ib
• 501 West DS, DiLillo V, Bursac Z et al. Motivational interviewing improves weight loss in women with type 2 diabetes. Diab Care 2007; 30 (05) 1081-1087 EK Ib
• 502 Pibernik-Okanovic M, Prasek M, Poljicanin-Filipovic T et al. Effects of an empowerment-based psychosocial intervention on quality of life and metabolic control in type 2 diabetic patients. Patient Educ Couns 2004; 52 (02) 193-199 EK IIb
• 503 Snoek FJ, van der Ven NC, Lubach CH et al. Effects of cognitive behavioural group training (CBGT) in adult patients with poorly controlled insulin-dependent (type 1) diabetes: a pilot study. Patient Educ Couns 2001; 45 (02) 143-148 EK IIb
• 504 Boehm S, Schlenk EA, Raleigh E et al. Behavioral analysis and behavioral strategies to improve self-management of type II diabetes. Clin Nurs Res 1993; 2 (03) 327-344 EK Ib
• 505 Bradshaw BG, Richardson GE, Kumpfer K et al. Determining the efficacy of a resiliency training approach in adults with type 2 diabetes. Diabetes Educ 2007; 33 (04) 650-659 EK Ib
• 506 Glasgow RE, La Chance PA, Toobert DJ et al. Long-term effects and costs of brief behavioural dietary intervention for patients with diabetes delivered from the medical office. Patient Educ Couns 1997; 32 (03) 175-184 EK Ib
• 507 Gregg JA, Callaghan GM, Hayes SC et al. Improving diabetes self-management through acceptance, mindfulness, and values: a randomized controlled trial. J Consult Clin Psychol 2007; 75 (02) 336-343 EK Ib
• 508 Rabkin SW, Boyko E, Wilson A et al. A randomized clinical trial comparing behavior modification and individual counseling in the nutritional therapy of non-insulin-dependent diabetes mellitus: comparison of the effect on blood sugar, body weight, and serum lipids. Diab Care 1983; 6 (01) 50-56 EK Ib
• 509 Rubak S, Sandbaek A, Lauritzen T et al. Effect of “motivational interviewing” on quality of care measures in screen detected type 2 diabetes patients: a one-year follow-up of an RCT, ADDITION Denmark. Scand J Prim Health Care 2011; 29 (02) 92-98 EK Ib
• 510 Snoek FJ, van der Ven NC, Twisk JW et al. Cognitive behavioural therapy (CBT) compared with blood glucose awareness training (BGAT) in poorly controlled Type 1 diabetic patients: long-term effects on HbA moderated by depression. A randomized controlled trial. Diabet Med 2008; 25 (11) 1337-1342 EK Ib
• 511 Welch G, Zagarins SE, Feinberg RG et al. Motivational interviewing delivered by diabetes educators: does it improve blood glucose control among poorly controlled type 2 diabetes patients?. Diabetes Res Clin Pract 2011; 91 (01) 54-60 EK Ib
• 512 Williams GC, McGregor H, Zeldman A et al. Promoting glycemic control through diabetes self-management: evaluating a patient activation intervention. Patient Educ Couns 2005; 56 (01) 28-34 EK Ib
• 513 Cummings SM, Cooper RL, McClure CK. Motivational Interviewing to Affect Behavioral Change in Older Adults. Research on Social Work Practice 2009; 19 (02) 195-204 EK Ib